| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 8.29e-24 | 46 | 37 | 12 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 EMID1 COL1A2 | 8.78e-18 | 188 | 37 | 13 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 EMID1 COL1A2 | 3.35e-09 | 891 | 37 | 13 | GO:0005198 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 1.27e-06 | 12 | 37 | 3 | GO:0048407 | |
| GeneOntologyMolecularFunction | dATP binding | 3.33e-05 | 5 | 37 | 2 | GO:0032564 | |
| GeneOntologyMolecularFunction | adenyl deoxyribonucleotide binding | 4.99e-05 | 6 | 37 | 2 | GO:0032558 | |
| GeneOntologyMolecularFunction | purine deoxyribonucleotide binding | 6.97e-05 | 7 | 37 | 2 | GO:0032554 | |
| GeneOntologyMolecularFunction | deoxyribonucleotide binding | 1.19e-04 | 9 | 37 | 2 | GO:0032552 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 2.07e-04 | 1160 | 37 | 9 | GO:0030674 | |
| GeneOntologyMolecularFunction | SMAD binding | 5.39e-04 | 86 | 37 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 6.55e-04 | 1356 | 37 | 9 | GO:0060090 | |
| GeneOntologyMolecularFunction | clathrin adaptor activity | 7.54e-04 | 22 | 37 | 2 | GO:0035615 | |
| GeneOntologyMolecularFunction | cargo adaptor activity | 9.76e-04 | 25 | 37 | 2 | GO:0140312 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.14e-03 | 37 | 37 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.31e-03 | 303 | 37 | 4 | GO:0003713 | |
| GeneOntologyMolecularFunction | growth factor binding | 2.99e-03 | 156 | 37 | 3 | GO:0019838 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 3.59e-03 | 562 | 37 | 5 | GO:0003712 | |
| GeneOntologyMolecularFunction | protease binding | 4.54e-03 | 181 | 37 | 3 | GO:0002020 | |
| GeneOntologyMolecularFunction | Hsp70 protein binding | 6.08e-03 | 63 | 37 | 2 | GO:0030544 | |
| GeneOntologyMolecularFunction | clathrin binding | 6.08e-03 | 63 | 37 | 2 | GO:0030276 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL2A1 COL3A1 SMARCA4 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 3.27e-14 | 377 | 36 | 13 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL2A1 COL3A1 SMARCA4 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 3.38e-14 | 378 | 36 | 13 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL2A1 COL3A1 SMARCA4 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 3.50e-14 | 379 | 36 | 13 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 3.65e-09 | 76 | 36 | 6 | GO:0030199 | |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 1.06e-06 | 12 | 36 | 3 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 3.91e-06 | 18 | 36 | 3 | GO:0038065 | |
| GeneOntologyBiologicalProcess | notochord development | 9.64e-06 | 24 | 36 | 3 | GO:0030903 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 1.73e-05 | 29 | 36 | 3 | GO:2000819 | |
| GeneOntologyBiologicalProcess | positive regulation of clathrin coat assembly | 1.77e-05 | 4 | 36 | 2 | GO:1905445 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 2.22e-05 | 95 | 36 | 4 | GO:0030071 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 2.51e-05 | 98 | 36 | 4 | GO:1902099 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 2.72e-05 | 100 | 36 | 4 | GO:0007091 | |
| GeneOntologyBiologicalProcess | negative regulation of protein refolding | 2.95e-05 | 5 | 36 | 2 | GO:0061084 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 3.05e-05 | 103 | 36 | 4 | GO:0044784 | |
| GeneOntologyBiologicalProcess | vasculature development | COL3A1 SMARCA2 SMARCA4 COL4A3 COL18A1 EPN1 CCBE1 COL27A1 COL1A2 | 3.21e-05 | 969 | 36 | 9 | GO:0001944 |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 4.10e-05 | 111 | 36 | 4 | GO:0033045 | |
| GeneOntologyBiologicalProcess | regulation of protein refolding | 4.42e-05 | 6 | 36 | 2 | GO:0061083 | |
| GeneOntologyBiologicalProcess | aortic smooth muscle cell differentiation | 4.42e-05 | 6 | 36 | 2 | GO:0035887 | |
| GeneOntologyBiologicalProcess | response to acid chemical | 4.50e-05 | 228 | 36 | 5 | GO:0001101 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 5.35e-05 | 42 | 36 | 3 | GO:0070316 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 6.16e-05 | 44 | 36 | 3 | GO:0045023 | |
| GeneOntologyBiologicalProcess | regulation of clathrin coat assembly | 6.19e-05 | 7 | 36 | 2 | GO:1905443 | |
| GeneOntologyBiologicalProcess | negative regulation of protein folding | 6.19e-05 | 7 | 36 | 2 | GO:1903333 | |
| GeneOntologyBiologicalProcess | skeletal system development | 7.96e-05 | 615 | 36 | 7 | GO:0001501 | |
| GeneOntologyBiologicalProcess | anterior head development | 8.24e-05 | 8 | 36 | 2 | GO:0097065 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 9.34e-05 | 266 | 36 | 5 | GO:0033044 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 9.84e-05 | 139 | 36 | 4 | GO:0051983 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 1.14e-04 | 54 | 36 | 3 | GO:0045663 | |
| GeneOntologyBiologicalProcess | circulatory system development | COL2A1 COL3A1 SMARCA2 SMARCA4 COL4A3 COL18A1 EPN1 CCBE1 COL27A1 COL1A2 | 1.28e-04 | 1442 | 36 | 10 | GO:0072359 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | COL2A1 COL3A1 SMARCA4 COL4A3 COL5A2 COL18A1 SSBP3 EPN1 CCBE1 COL27A1 | 1.61e-04 | 1483 | 36 | 10 | GO:0048646 |
| GeneOntologyBiologicalProcess | blood vessel development | 1.61e-04 | 929 | 36 | 8 | GO:0001568 | |
| GeneOntologyBiologicalProcess | cellular response to amino acid stimulus | 1.73e-04 | 161 | 36 | 4 | GO:0071230 | |
| GeneOntologyBiologicalProcess | cellular response to acid chemical | 2.49e-04 | 177 | 36 | 4 | GO:0071229 | |
| GeneOntologyBiologicalProcess | regulation of protein folding | 2.66e-04 | 14 | 36 | 2 | GO:1903332 | |
| GeneOntologyBiologicalProcess | endothelial cell morphogenesis | 3.07e-04 | 15 | 36 | 2 | GO:0001886 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 3.52e-04 | 79 | 36 | 3 | GO:0060350 | |
| GeneOntologyBiologicalProcess | response to amino acid | 4.11e-04 | 202 | 36 | 4 | GO:0043200 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 4.55e-04 | 817 | 36 | 7 | GO:0048514 | |
| GeneOntologyBiologicalProcess | nucleotide-excision repair | 4.84e-04 | 88 | 36 | 3 | GO:0006289 | |
| GeneOntologyBiologicalProcess | tube development | COL2A1 COL3A1 SMARCA4 COL4A3 COL18A1 SSBP3 EPN1 CCBE1 COL27A1 | 5.31e-04 | 1402 | 36 | 9 | GO:0035295 |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 5.51e-04 | 92 | 36 | 3 | GO:0045661 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 6.05e-04 | 95 | 36 | 3 | GO:2000781 | |
| GeneOntologyBiologicalProcess | clathrin coat assembly | 7.32e-04 | 23 | 36 | 2 | GO:0048268 | |
| GeneOntologyBiologicalProcess | U2-type prespliceosome assembly | 8.66e-04 | 25 | 36 | 2 | GO:1903241 | |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 9.71e-04 | 254 | 36 | 4 | GO:0000819 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | 1.16e-03 | 957 | 36 | 7 | GO:0097435 | |
| GeneOntologyBiologicalProcess | protein refolding | 1.25e-03 | 30 | 36 | 2 | GO:0042026 | |
| GeneOntologyBiologicalProcess | bone morphogenesis | 1.31e-03 | 124 | 36 | 3 | GO:0060349 | |
| GeneOntologyBiologicalProcess | chondrocyte differentiation | 1.60e-03 | 133 | 36 | 3 | GO:0002062 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription termination | 1.60e-03 | 34 | 36 | 2 | GO:0006353 | |
| GeneOntologyBiologicalProcess | chaperone cofactor-dependent protein refolding | 1.70e-03 | 35 | 36 | 2 | GO:0051085 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 1.71e-03 | 136 | 36 | 3 | GO:0045445 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | 1.91e-03 | 516 | 36 | 5 | GO:1901987 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 1.97e-03 | 143 | 36 | 3 | GO:0045739 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 2.01e-03 | 144 | 36 | 3 | GO:0045582 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 2.09e-03 | 146 | 36 | 3 | GO:2000779 | |
| GeneOntologyBiologicalProcess | 'de novo' post-translational protein folding | 2.33e-03 | 41 | 36 | 2 | GO:0051084 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 2.61e-03 | 333 | 36 | 4 | GO:0051054 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 2.75e-03 | 561 | 36 | 5 | GO:0048568 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 2.81e-03 | 162 | 36 | 3 | GO:0045621 | |
| GeneOntologyBiologicalProcess | embryo development | 2.84e-03 | 1437 | 36 | 8 | GO:0009790 | |
| GeneOntologyBiologicalProcess | 'de novo' protein folding | 2.92e-03 | 46 | 36 | 2 | GO:0006458 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 2.92e-03 | 1125 | 36 | 7 | GO:0035239 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 3.05e-03 | 47 | 36 | 2 | GO:0060351 | |
| GeneOntologyBiologicalProcess | epithelial cell morphogenesis | 3.31e-03 | 49 | 36 | 2 | GO:0003382 | |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | 3.32e-03 | 356 | 36 | 4 | GO:0098813 | |
| GeneOntologyBiologicalProcess | response to angiotensin | 3.44e-03 | 50 | 36 | 2 | GO:1990776 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | 3.51e-03 | 594 | 36 | 5 | GO:0007346 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 3.58e-03 | 51 | 36 | 2 | GO:1902459 | |
| GeneOntologyBiologicalProcess | skin development | 3.93e-03 | 373 | 36 | 4 | GO:0043588 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 4.08e-03 | 185 | 36 | 3 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 4.08e-03 | 185 | 36 | 3 | GO:0035108 | |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle cell differentiation | 4.15e-03 | 55 | 36 | 2 | GO:0035886 | |
| GeneOntologyCellularComponent | collagen trimer | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 C1QC COL5A2 COL18A1 COL24A1 COL9A2 C1QTNF2 COL17A1 COL26A1 MARCO CCBE1 COL27A1 EMID1 COL1A2 | 4.47e-34 | 88 | 37 | 18 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | 8.56e-18 | 21 | 37 | 8 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 C1QC COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL26A1 MARCO COL27A1 EMID1 COL1A2 | 1.84e-16 | 530 | 37 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 C1QC COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL26A1 MARCO CCBE1 COL27A1 EMID1 COL1A2 | 2.01e-16 | 656 | 37 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 C1QC COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL26A1 MARCO CCBE1 COL27A1 EMID1 COL1A2 | 2.11e-16 | 658 | 37 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL26A1 COL27A1 COL1A2 | 8.19e-15 | 332 | 37 | 13 | GO:0005788 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.03e-11 | 12 | 37 | 5 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.03e-11 | 12 | 37 | 5 | GO:0098643 | |
| GeneOntologyCellularComponent | basement membrane | 7.00e-08 | 122 | 37 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.02e-07 | 6 | 37 | 3 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 2.84e-07 | 8 | 37 | 3 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 2.84e-07 | 8 | 37 | 3 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 2.84e-07 | 8 | 37 | 3 | GO:0098645 | |
| GeneOntologyCellularComponent | bBAF complex | 6.07e-07 | 10 | 37 | 3 | GO:0140092 | |
| GeneOntologyCellularComponent | npBAF complex | 1.83e-06 | 14 | 37 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | nBAF complex | 2.81e-06 | 16 | 37 | 3 | GO:0071565 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 2.01e-05 | 30 | 37 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 3.04e-05 | 5 | 37 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 ZNF207 COL27A1 COL1A2 | 1.75e-04 | 1187 | 37 | 9 | GO:0099081 |
| GeneOntologyCellularComponent | GBAF complex | 2.74e-04 | 14 | 37 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | brahma complex | 2.74e-04 | 14 | 37 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | extrinsic component of presynaptic membrane | 4.58e-04 | 18 | 37 | 2 | GO:0098888 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 6.51e-04 | 96 | 37 | 3 | GO:0070603 | |
| GeneOntologyCellularComponent | U2 snRNP | 1.12e-03 | 28 | 37 | 2 | GO:0005686 | |
| GeneOntologyCellularComponent | U12-type spliceosomal complex | 1.29e-03 | 30 | 37 | 2 | GO:0005689 | |
| GeneOntologyCellularComponent | ATPase complex | 1.53e-03 | 129 | 37 | 3 | GO:1904949 | |
| GeneOntologyCellularComponent | extrinsic component of synaptic membrane | 1.75e-03 | 35 | 37 | 2 | GO:0099243 | |
| GeneOntologyCellularComponent | clathrin vesicle coat | 2.06e-03 | 38 | 37 | 2 | GO:0030125 | |
| GeneOntologyCellularComponent | U2-type precatalytic spliceosome | 3.68e-03 | 51 | 37 | 2 | GO:0071005 | |
| GeneOntologyCellularComponent | precatalytic spliceosome | 4.12e-03 | 54 | 37 | 2 | GO:0071011 | |
| GeneOntologyCellularComponent | clathrin coat | 4.42e-03 | 56 | 37 | 2 | GO:0030118 | |
| GeneOntologyCellularComponent | vesicle coat | 6.27e-03 | 67 | 37 | 2 | GO:0030120 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 8.83e-03 | 80 | 37 | 2 | GO:0005905 | |
| GeneOntologyCellularComponent | spliceosomal snRNP complex | 1.25e-02 | 96 | 37 | 2 | GO:0097525 | |
| GeneOntologyCellularComponent | U2-type spliceosomal complex | 1.28e-02 | 97 | 37 | 2 | GO:0005684 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.28e-02 | 277 | 37 | 3 | GO:0042734 | |
| GeneOntologyCellularComponent | membrane coat | 1.51e-02 | 106 | 37 | 2 | GO:0030117 | |
| GeneOntologyCellularComponent | coated membrane | 1.51e-02 | 106 | 37 | 2 | GO:0048475 | |
| GeneOntologyCellularComponent | small nuclear ribonucleoprotein complex | 1.54e-02 | 107 | 37 | 2 | GO:0030532 | |
| GeneOntologyCellularComponent | supramolecular fiber | 1.65e-02 | 1179 | 37 | 6 | GO:0099512 | |
| HumanPheno | Prominent interphalangeal joints | 1.03e-06 | 6 | 20 | 3 | HP:0006237 | |
| HumanPheno | Arterial rupture | 2.86e-06 | 8 | 20 | 3 | HP:0025019 | |
| HumanPheno | Lenticonus | 6.11e-06 | 10 | 20 | 3 | HP:0001142 | |
| HumanPheno | Joint dislocation | COL2A1 COL3A1 SMARCA2 COL5A2 ARID1B SF3B4 SNRPB COL27A1 COL1A2 | 6.48e-06 | 390 | 20 | 9 | HP:0001373 |
| HumanPheno | Abnormal hip bone morphology | COL2A1 COL3A1 SMARCA2 COL5A2 COL9A2 ARID1B SF3B4 SNRPB CCBE1 COL27A1 COL1A2 | 7.95e-06 | 653 | 20 | 11 | HP:0003272 |
| HumanPheno | Abnormal joint physiology | COL2A1 COL3A1 SMARCA2 SMARCA4 COL5A2 COL18A1 COL9A2 ARID1B SF3B4 COL17A1 SNRPB CCBE1 COL27A1 SCAF4 COL1A2 | 8.64e-06 | 1358 | 20 | 15 | HP:0034430 |
| HumanPheno | Abnormality of joint mobility | COL2A1 COL3A1 SMARCA2 SMARCA4 COL5A2 COL18A1 COL9A2 ARID1B SF3B4 COL17A1 SNRPB CCBE1 COL27A1 SCAF4 COL1A2 | 8.64e-06 | 1358 | 20 | 15 | HP:0011729 |
| HumanPheno | Atrophic scars | 1.05e-05 | 37 | 20 | 4 | HP:0001075 | |
| HumanPheno | Fragile skin | 1.05e-05 | 37 | 20 | 4 | HP:0001030 | |
| HumanPheno | Abnormal mitral valve morphology | 1.39e-05 | 146 | 20 | 6 | HP:0031477 | |
| HumanPheno | Tracheobronchial leiomyomatosis | 1.46e-05 | 2 | 20 | 2 | HP:0006524 | |
| HumanPheno | Dyspepsia | 1.46e-05 | 2 | 20 | 2 | HP:0410281 | |
| HumanPheno | Diffuse leiomyomatosis | 1.46e-05 | 2 | 20 | 2 | HP:0006756 | |
| HumanPheno | Joint hypermobility | COL2A1 COL3A1 SMARCA2 SMARCA4 COL5A2 COL18A1 COL9A2 ARID1B SCAF4 COL1A2 | 1.51e-05 | 557 | 20 | 10 | HP:0001382 |
| HumanPheno | Abnormality of refraction | COL2A1 COL3A1 SMARCA4 COL4A3 COL4A5 COL4A6 COL18A1 COL9A2 ARID1B COL17A1 COL1A2 | 1.78e-05 | 709 | 20 | 11 | HP:0000539 |
| HumanPheno | Myopia | COL2A1 SMARCA4 COL4A3 COL4A5 COL4A6 COL18A1 COL9A2 ARID1B COL1A2 | 1.99e-05 | 447 | 20 | 9 | HP:0000545 |
| HumanPheno | Abnormal pelvic girdle bone morphology | COL2A1 COL3A1 SMARCA2 COL5A2 COL9A2 ARID1B SF3B4 SNRPB CCBE1 COL27A1 COL1A2 | 2.37e-05 | 730 | 20 | 11 | HP:0002644 |
| HumanPheno | Hip dysplasia | 2.61e-05 | 247 | 20 | 7 | HP:0001385 | |
| HumanPheno | Abnormal upper limb bone morphology | COL2A1 COL3A1 SMARCA2 COL5A2 COL9A2 ARID1B SF3B4 SNRPB COL27A1 | 3.79e-05 | 484 | 20 | 9 | HP:0040070 |
| HumanPheno | Hip dislocation | 3.92e-05 | 263 | 20 | 7 | HP:0002827 | |
| HumanPheno | Abnormality of lens shape | 4.07e-05 | 18 | 20 | 3 | HP:0011526 | |
| HumanPheno | Abnormal hip joint morphology | COL2A1 COL3A1 SMARCA2 COL5A2 COL9A2 SF3B4 SNRPB COL27A1 COL1A2 | 4.18e-05 | 490 | 20 | 9 | HP:0001384 |
| HumanPheno | Flat face | 4.29e-05 | 106 | 20 | 5 | HP:0012368 | |
| HumanPheno | Glomerular basement membrane lamellation | 4.38e-05 | 3 | 20 | 2 | HP:0030034 | |
| HumanPheno | Hypermobility of distal interphalangeal joints | 4.38e-05 | 3 | 20 | 2 | HP:0006201 | |
| HumanPheno | Anterior lenticonus | 4.38e-05 | 3 | 20 | 2 | HP:0011501 | |
| HumanPheno | Short phalanx of the 5th toe | 4.38e-05 | 3 | 20 | 2 | HP:0100368 | |
| HumanPheno | Vulvar neoplasm | 4.38e-05 | 3 | 20 | 2 | HP:0030416 | |
| HumanPheno | Precordial pain | 4.38e-05 | 3 | 20 | 2 | HP:0032141 | |
| HumanPheno | Abnormal synovial membrane morphology | COL2A1 COL3A1 SMARCA2 COL5A2 COL9A2 SF3B4 SNRPB COL27A1 COL1A2 | 5.16e-05 | 503 | 20 | 9 | HP:0005262 |
| HumanPheno | Neoplasm by histology | 5.35e-05 | 383 | 20 | 8 | HP:0011792 | |
| HumanPheno | Abnormality of the elbow | 6.14e-05 | 282 | 20 | 7 | HP:0009811 | |
| HumanPheno | Vitreoretinopathy | 7.60e-05 | 22 | 20 | 3 | HP:0007773 | |
| HumanPheno | Aplasia/Hypoplasia involving bones of the feet | 8.75e-05 | 298 | 20 | 7 | HP:0006494 | |
| HumanPheno | Cervical insufficiency | 8.75e-05 | 4 | 20 | 2 | HP:0030009 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th toe | 8.75e-05 | 4 | 20 | 2 | HP:0010343 | |
| HumanPheno | Mitral valve prolapse | 8.77e-05 | 123 | 20 | 5 | HP:0001634 | |
| HumanPheno | Short 5th finger | 9.44e-05 | 64 | 20 | 4 | HP:0009237 | |
| HumanPheno | Osteoarthritis | 1.00e-04 | 65 | 20 | 4 | HP:0002758 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th finger | 1.07e-04 | 66 | 20 | 4 | HP:0006262 | |
| HumanPheno | Coxa vara | 1.20e-04 | 68 | 20 | 4 | HP:0002812 | |
| HumanPheno | Abnormal morphology of the radius | 1.31e-04 | 217 | 20 | 6 | HP:0002818 | |
| HumanPheno | Lower extremity joint dislocation | 1.32e-04 | 318 | 20 | 7 | HP:0030311 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | COL2A1 COL3A1 SMARCA2 SMARCA4 COL9A2 ARID1B SF3B4 SNRPB CCBE1 | 1.43e-04 | 572 | 20 | 9 | HP:0006496 |
| HumanPheno | Hypermobility of interphalangeal joints | 1.45e-04 | 5 | 20 | 2 | HP:0005620 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the 5th toe | 1.45e-04 | 5 | 20 | 2 | HP:0010383 | |
| HumanPheno | Abnormality of the phalanges of the 5th toe | 1.45e-04 | 5 | 20 | 2 | HP:0010342 | |
| HumanPheno | Abnormal neural tube morphology | 1.49e-04 | 324 | 20 | 7 | HP:0410043 | |
| HumanPheno | Neural tube defect | 1.49e-04 | 324 | 20 | 7 | HP:0045005 | |
| HumanPheno | Wide nasal base | 1.59e-04 | 28 | 20 | 3 | HP:0012810 | |
| HumanPheno | Atypical scarring of skin | 1.67e-04 | 74 | 20 | 4 | HP:0000987 | |
| HumanPheno | Abnormal morphology of the great vessels | COL3A1 SMARCA2 SMARCA4 COL5A2 COL18A1 ARID1B SF3B4 SNRPB SCAF4 COL1A2 | 1.74e-04 | 736 | 20 | 10 | HP:0030962 |
| HumanPheno | Hernia | COL2A1 COL3A1 SMARCA2 SMARCA4 COL5A2 ARID1B SF3B4 CCBE1 COL1A2 | 1.80e-04 | 589 | 20 | 9 | HP:0100790 |
| HumanPheno | Abnormal nasal base norphology | 1.96e-04 | 30 | 20 | 3 | HP:0012808 | |
| HumanPheno | Abnormal forearm bone morphology | 2.08e-04 | 236 | 20 | 6 | HP:0040072 | |
| HumanPheno | Closed neural tube defect | 2.15e-04 | 79 | 20 | 4 | HP:0034238 | |
| HumanPheno | Abnormal forearm morphology | 2.23e-04 | 239 | 20 | 6 | HP:0002973 | |
| HumanPheno | Hallux valgus | 2.26e-04 | 80 | 20 | 4 | HP:0001822 | |
| HumanPheno | Malar flattening | 2.28e-04 | 240 | 20 | 6 | HP:0000272 | |
| HumanPheno | Preauricular skin tag | 2.37e-04 | 81 | 20 | 4 | HP:0000384 | |
| HumanPheno | Periauricular skin tag | 2.37e-04 | 81 | 20 | 4 | HP:0100278 | |
| HumanPheno | Epicanthus | COL3A1 SMARCA2 COL5A2 COL18A1 ARID1B SNRPB CCBE1 SCAF4 COL1A2 | 2.48e-04 | 614 | 20 | 9 | HP:0000286 |
| HumanPheno | Scoliosis | COL2A1 COL3A1 SMARCA2 SMARCA4 COL5A2 ARID1B SF3B4 SNRPB CCBE1 COL27A1 SCAF4 COL1A2 | 2.62e-04 | 1122 | 20 | 12 | HP:0002650 |
| HumanPheno | Bell-shaped thorax | 2.62e-04 | 33 | 20 | 3 | HP:0001591 | |
| HumanPheno | Abnormal malar bone morphology | 2.79e-04 | 249 | 20 | 6 | HP:0012369 | |
| HumanPheno | Abnormal thorax morphology | COL2A1 COL3A1 SMARCA2 COL4A5 COL4A6 COL5A2 EWSR1 ARID1B SF3B4 SNRPB CCBE1 SCAF4 COL1A2 | 2.81e-04 | 1328 | 20 | 13 | HP:0000765 |
| HumanPheno | Abnormal zygomatic arch morphology | 2.85e-04 | 250 | 20 | 6 | HP:0005557 | |
| HumanPheno | Abnormal zygomatic bone morphology | 2.85e-04 | 250 | 20 | 6 | HP:0010668 | |
| HumanPheno | Abnormal uterus morphology | 2.86e-04 | 158 | 20 | 5 | HP:0031105 | |
| HumanPheno | Pierre-Robin sequence | 2.87e-04 | 34 | 20 | 3 | HP:0000201 | |
| HumanPheno | Abnormal femoral neck morphology | 3.04e-04 | 160 | 20 | 5 | HP:0003367 | |
| HumanPheno | Short distal phalanx of the 5th finger | 3.04e-04 | 7 | 20 | 2 | HP:0004227 | |
| HumanPheno | Aplasia/Hypoplasia of the distal phalanx of the 5th finger | 3.04e-04 | 7 | 20 | 2 | HP:0009239 | |
| HumanPheno | Molluscoid pseudotumors | 3.04e-04 | 7 | 20 | 2 | HP:0000993 | |
| HumanPheno | Uterine prolapse | 3.04e-04 | 7 | 20 | 2 | HP:0000139 | |
| HumanPheno | Abnormality of the uterus | 3.24e-04 | 256 | 20 | 6 | HP:0000130 | |
| HumanPheno | Deviation of the hallux | 3.26e-04 | 88 | 20 | 4 | HP:0010051 | |
| HumanPheno | Abnormality of dental structure | 3.30e-04 | 368 | 20 | 7 | HP:0011061 | |
| HumanPheno | Abnormal mitral valve morphology | 3.31e-04 | 257 | 20 | 6 | HP:0001633 | |
| HumanPheno | Bladder diverticulum | 3.40e-04 | 36 | 20 | 3 | HP:0000015 | |
| HumanPheno | Coxa valga | 3.87e-04 | 92 | 20 | 4 | HP:0002673 | |
| HumanPheno | Genital hernia | 4.04e-04 | 8 | 20 | 2 | HP:0100823 | |
| HumanPheno | Anti-smooth muscle antibody positivity | 4.04e-04 | 8 | 20 | 2 | HP:0003262 | |
| HumanPheno | Aplasia/hypoplasia of the extremities | COL2A1 COL3A1 SMARCA2 SMARCA4 COL9A2 ARID1B SF3B4 SNRPB CCBE1 COL1A2 | 4.05e-04 | 813 | 20 | 10 | HP:0009815 |
| HumanPheno | Abdominal wall defect | 4.10e-04 | 511 | 20 | 8 | HP:0010866 | |
| HumanPheno | Thoracoabdominal wall defect | 4.10e-04 | 511 | 20 | 8 | HP:0100656 | |
| HumanPheno | Spina bifida | 4.14e-04 | 171 | 20 | 5 | HP:0002414 | |
| HumanPheno | Thick nasal alae | 4.32e-04 | 39 | 20 | 3 | HP:0009928 | |
| HumanPheno | Aspiration pneumonia | 4.37e-04 | 95 | 20 | 4 | HP:0011951 | |
| HumanPheno | Upper extremity joint dislocation | 4.55e-04 | 96 | 20 | 4 | HP:0030310 | |
| HumanPheno | Skin tags | 4.74e-04 | 97 | 20 | 4 | HP:0010609 | |
| HumanPheno | Sparse or absent hair | 4.94e-04 | 525 | 20 | 8 | HP:0002115 | |
| HumanPheno | Arthralgia of the hip | 5.19e-04 | 9 | 20 | 2 | HP:0003365 | |
| HumanPheno | Talipes equinovarus | 5.42e-04 | 399 | 20 | 7 | HP:0001762 | |
| HumanPheno | Scarring | 5.74e-04 | 102 | 20 | 4 | HP:0100699 | |
| HumanPheno | Juvenile aseptic necrosis | 5.78e-04 | 43 | 20 | 3 | HP:0100323 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | 5.84e-04 | 538 | 20 | 8 | HP:0005927 | |
| HumanPheno | Abnormality of lower limb joint | COL2A1 COL3A1 SMARCA2 COL5A2 COL9A2 ARID1B SF3B4 SNRPB CCBE1 COL27A1 COL1A2 | 5.89e-04 | 1027 | 20 | 11 | HP:0100491 |
| HumanPheno | Abnormal curvature of the vertebral column | COL2A1 COL3A1 SMARCA2 SMARCA4 COL5A2 ARID1B SF3B4 SNRPB CCBE1 COL27A1 SCAF4 COL1A2 | 5.96e-04 | 1219 | 20 | 12 | HP:0010674 |
| HumanPheno | Abnormality of the dentition | COL2A1 COL3A1 SMARCA2 SMARCA4 COL5A2 COL9A2 ARID1B COL17A1 SNRPB CCBE1 COL1A2 | 6.05e-04 | 1030 | 20 | 11 | HP:0000164 |
| MousePheno | podocyte foot process effacement | 2.03e-06 | 38 | 34 | 4 | MP:0008140 | |
| MousePheno | abnormal podocyte foot process morphology | 9.11e-06 | 55 | 34 | 4 | MP:0008059 | |
| MousePheno | abnormal podocyte morphology | 2.39e-05 | 70 | 34 | 4 | MP:0005326 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 2.39e-05 | 70 | 34 | 4 | MP:0011497 | |
| MousePheno | increased large unstained cell number | 1.05e-04 | 38 | 34 | 3 | MP:0012362 | |
| MousePheno | retrognathia | 1.20e-04 | 7 | 34 | 2 | MP:0004282 | |
| MousePheno | abnormal basement membrane morphology | 1.22e-04 | 40 | 34 | 3 | MP:0004272 | |
| MousePheno | abnormal renal glomerular capsule morphology | 1.26e-04 | 107 | 34 | 4 | MP:0002828 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 1.63e-04 | 44 | 34 | 3 | MP:0011348 | |
| MousePheno | expanded mesangial matrix | 1.86e-04 | 46 | 34 | 3 | MP:0011353 | |
| MousePheno | abnormal mesangial matrix morphology | 2.53e-04 | 51 | 34 | 3 | MP:0011338 | |
| MousePheno | abnormal large unstained cell number | 2.83e-04 | 53 | 34 | 3 | MP:0012360 | |
| MousePheno | kidney hemorrhage | 5.13e-04 | 14 | 34 | 2 | MP:0000533 | |
| Domain | Collagen | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 C1QC COL5A2 COL18A1 COL24A1 COL9A2 C1QTNF2 COL17A1 COL26A1 MARCO CCBE1 COL27A1 EMID1 COL1A2 | 1.69e-33 | 85 | 37 | 18 | PF01391 |
| Domain | Collagen | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 C1QC COL5A2 COL18A1 COL24A1 COL9A2 C1QTNF2 COL17A1 COL26A1 MARCO CCBE1 COL27A1 EMID1 COL1A2 | 1.69e-33 | 85 | 37 | 18 | IPR008160 |
| Domain | NC1_FIB | 1.81e-14 | 11 | 37 | 6 | PS51461 | |
| Domain | Fib_collagen_C | 1.81e-14 | 11 | 37 | 6 | IPR000885 | |
| Domain | Fib_collagen_C | 1.81e-14 | 11 | 37 | 6 | PD002078 | |
| Domain | COLFI | 1.81e-14 | 11 | 37 | 6 | SM00038 | |
| Domain | COLFI | 1.81e-14 | 11 | 37 | 6 | PF01410 | |
| Domain | C4 | 1.43e-07 | 6 | 37 | 3 | SM00111 | |
| Domain | - | 1.43e-07 | 6 | 37 | 3 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 1.43e-07 | 6 | 37 | 3 | IPR001442 | |
| Domain | NC1_IV | 1.43e-07 | 6 | 37 | 3 | PS51403 | |
| Domain | C4 | 1.43e-07 | 6 | 37 | 3 | PF01413 | |
| Domain | RRM_1 | 3.09e-06 | 208 | 37 | 6 | PF00076 | |
| Domain | SnAC | 3.82e-06 | 2 | 37 | 2 | SM01314 | |
| Domain | QLQ | 3.82e-06 | 2 | 37 | 2 | PS51666 | |
| Domain | Gln-Leu-Gln_QLQ | 3.82e-06 | 2 | 37 | 2 | IPR014978 | |
| Domain | SnAC | 3.82e-06 | 2 | 37 | 2 | IPR029295 | |
| Domain | QLQ | 3.82e-06 | 2 | 37 | 2 | PF08880 | |
| Domain | SnAC | 3.82e-06 | 2 | 37 | 2 | PF14619 | |
| Domain | QLQ | 3.82e-06 | 2 | 37 | 2 | SM00951 | |
| Domain | RRM | 3.95e-06 | 217 | 37 | 6 | SM00360 | |
| Domain | RRM_dom | 5.12e-06 | 227 | 37 | 6 | IPR000504 | |
| Domain | RRM | 5.52e-06 | 230 | 37 | 6 | PS50102 | |
| Domain | - | 7.74e-06 | 244 | 37 | 6 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.06e-05 | 258 | 37 | 6 | IPR012677 | |
| Domain | SSDP_DNA-bd | 1.14e-05 | 3 | 37 | 2 | IPR008116 | |
| Domain | TSPN | 1.23e-05 | 23 | 37 | 3 | SM00210 | |
| Domain | - | 1.80e-05 | 26 | 37 | 3 | 1.25.40.90 | |
| Domain | VWC | 2.27e-05 | 28 | 37 | 3 | PF00093 | |
| Domain | HSA | 2.29e-05 | 4 | 37 | 2 | SM00573 | |
| Domain | HSA | 2.29e-05 | 4 | 37 | 2 | PS51204 | |
| Domain | HSA_dom | 2.29e-05 | 4 | 37 | 2 | IPR014012 | |
| Domain | HSA | 2.29e-05 | 4 | 37 | 2 | PF07529 | |
| Domain | ENTH_VHS | 2.52e-05 | 29 | 37 | 3 | IPR008942 | |
| Domain | VWFC_1 | 4.88e-05 | 36 | 37 | 3 | PS01208 | |
| Domain | BRK | 5.70e-05 | 6 | 37 | 2 | SM00592 | |
| Domain | BRK_domain | 5.70e-05 | 6 | 37 | 2 | IPR006576 | |
| Domain | BRK | 5.70e-05 | 6 | 37 | 2 | PF07533 | |
| Domain | VWC | 5.76e-05 | 38 | 37 | 3 | SM00214 | |
| Domain | VWFC_2 | 5.76e-05 | 38 | 37 | 3 | PS50184 | |
| Domain | CTDL_fold | 5.81e-05 | 107 | 37 | 4 | IPR016187 | |
| Domain | - | 6.72e-05 | 40 | 37 | 3 | 4.10.1000.10 | |
| Domain | VWF_dom | 7.79e-05 | 42 | 37 | 3 | IPR001007 | |
| Domain | zf-CCCH | 1.24e-04 | 49 | 37 | 3 | PF00642 | |
| Domain | ENTH | 1.36e-04 | 9 | 37 | 2 | PS50942 | |
| Domain | ENTH | 1.36e-04 | 9 | 37 | 2 | SM00273 | |
| Domain | EMI | 1.70e-04 | 10 | 37 | 2 | PF07546 | |
| Domain | STI1_HS-bd | 1.70e-04 | 10 | 37 | 2 | IPR006636 | |
| Domain | STI1 | 1.70e-04 | 10 | 37 | 2 | SM00727 | |
| Domain | ENTH | 1.70e-04 | 10 | 37 | 2 | IPR013809 | |
| Domain | Laminin_G | 2.05e-04 | 58 | 37 | 3 | IPR001791 | |
| Domain | Znf_CCCH | 2.05e-04 | 58 | 37 | 3 | IPR000571 | |
| Domain | ZF_C3H1 | 2.05e-04 | 58 | 37 | 3 | PS50103 | |
| Domain | EMI_domain | 4.50e-04 | 16 | 37 | 2 | IPR011489 | |
| Domain | EMI | 5.10e-04 | 17 | 37 | 2 | PS51041 | |
| Domain | Bromodomain_CS | 1.20e-03 | 26 | 37 | 2 | IPR018359 | |
| Domain | LisH | 1.40e-03 | 28 | 37 | 2 | IPR006594 | |
| Domain | LisH | 1.40e-03 | 28 | 37 | 2 | SM00667 | |
| Domain | LISH | 1.40e-03 | 28 | 37 | 2 | PS50896 | |
| Domain | C1Q | 1.82e-03 | 32 | 37 | 2 | SM00110 | |
| Domain | SNF2_N | 1.82e-03 | 32 | 37 | 2 | PF00176 | |
| Domain | SNF2_N | 1.82e-03 | 32 | 37 | 2 | IPR000330 | |
| Domain | C1q | 1.82e-03 | 32 | 37 | 2 | PF00386 | |
| Domain | C1q_dom | 2.06e-03 | 34 | 37 | 2 | IPR001073 | |
| Domain | C1Q | 2.06e-03 | 34 | 37 | 2 | PS50871 | |
| Domain | BROMODOMAIN_1 | 2.43e-03 | 37 | 37 | 2 | PS00633 | |
| Domain | LAM_G_DOMAIN | 2.57e-03 | 38 | 37 | 2 | PS50025 | |
| Domain | Bromodomain | 2.57e-03 | 38 | 37 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 2.98e-03 | 41 | 37 | 2 | PS50014 | |
| Domain | BROMO | 3.13e-03 | 42 | 37 | 2 | SM00297 | |
| Domain | Bromodomain | 3.13e-03 | 42 | 37 | 2 | IPR001487 | |
| Domain | - | 3.13e-03 | 42 | 37 | 2 | 1.20.920.10 | |
| Domain | ZnF_C3H1 | 4.07e-03 | 48 | 37 | 2 | SM00356 | |
| Domain | - | 4.41e-03 | 50 | 37 | 2 | 2.60.120.40 | |
| Domain | Tumour_necrosis_fac-like_dom | 5.89e-03 | 58 | 37 | 2 | IPR008983 | |
| Domain | ConA-like_dom | 9.21e-03 | 219 | 37 | 3 | IPR013320 | |
| Domain | TPR_1 | 1.37e-02 | 90 | 37 | 2 | PF00515 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL26A1 COL27A1 COL1A2 | 1.36e-26 | 44 | 28 | 13 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL26A1 COL27A1 COL1A2 | 6.49e-24 | 67 | 28 | 13 | M26999 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 3.93e-22 | 61 | 28 | 12 | M27103 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL26A1 COL27A1 COL1A2 | 4.11e-22 | 90 | 28 | 13 | M631 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL9A2 COL17A1 COL26A1 COL1A2 | 6.02e-22 | 41 | 28 | 11 | MM15538 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL9A2 COL17A1 COL26A1 COL1A2 | 7.79e-20 | 61 | 28 | 11 | MM14637 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL9A2 COL17A1 COL26A1 COL1A2 | 1.38e-19 | 64 | 28 | 11 | M26953 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL9A2 COL17A1 COL26A1 COL1A2 | 1.05e-18 | 76 | 28 | 11 | MM14573 |
| Pathway | PID_SYNDECAN_1_PATHWAY | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL9A2 COL17A1 COL1A2 | 1.20e-16 | 46 | 28 | 9 | M198 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL9A2 COL1A2 | 2.72e-16 | 50 | 28 | 9 | MM14796 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL26A1 COL1A2 | 4.80e-16 | 53 | 28 | 9 | MM14566 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL9A2 COL17A1 COL26A1 COL1A2 | 1.16e-15 | 140 | 28 | 11 | M587 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL26A1 COL27A1 COL1A2 | 3.99e-15 | 300 | 28 | 13 | M610 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL9A2 COL17A1 COL1A2 | 1.17e-14 | 74 | 28 | 9 | M160 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL9A2 COL1A2 | 1.50e-14 | 76 | 28 | 9 | MM14867 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL9A2 COL1A2 | 4.29e-14 | 85 | 28 | 9 | M16441 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.76e-13 | 32 | 28 | 7 | MM14924 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 4.30e-13 | 66 | 28 | 8 | M18 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL26A1 COL1A2 | 6.52e-13 | 114 | 28 | 9 | MM14571 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL9A2 COL17A1 COL26A1 COL1A2 | 1.02e-12 | 258 | 28 | 11 | MM14572 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.32e-12 | 20 | 28 | 6 | MM15061 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.39e-12 | 76 | 28 | 8 | M27219 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.72e-11 | 59 | 28 | 7 | M27218 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.99e-11 | 30 | 28 | 6 | M27772 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 9.15e-11 | 38 | 28 | 6 | MM14969 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.48e-10 | 41 | 28 | 6 | M27778 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.73e-10 | 42 | 28 | 6 | M7169 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.17e-09 | 57 | 28 | 6 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.31e-09 | 58 | 28 | 6 | M2049 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.18e-09 | 63 | 28 | 6 | M11187 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 8.72e-09 | 79 | 28 | 6 | M27643 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.67e-08 | 15 | 28 | 4 | M27161 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.07e-08 | 47 | 28 | 5 | MM14925 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 3.74e-08 | 18 | 28 | 4 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 3.74e-08 | 18 | 28 | 4 | MM14882 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL3A1 COL4A3 COL4A5 COL5A2 COL24A1 COL9A2 EPN1 COL27A1 COL1A2 | 3.83e-08 | 532 | 28 | 10 | M27870 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 4.73e-08 | 19 | 28 | 4 | MM15512 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.29e-07 | 30 | 28 | 4 | M27216 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.29e-07 | 30 | 28 | 4 | MM15517 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 5.88e-07 | 84 | 28 | 5 | M7098 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 8.34e-07 | 10 | 28 | 3 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 8.34e-07 | 10 | 28 | 3 | MM1560 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.03e-06 | 418 | 28 | 8 | MM15587 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.15e-06 | 11 | 28 | 3 | M15422 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.46e-06 | 43 | 28 | 4 | M53 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.53e-06 | 12 | 28 | 3 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.98e-06 | 13 | 28 | 3 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.98e-06 | 13 | 28 | 3 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.52e-06 | 14 | 28 | 3 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.52e-06 | 14 | 28 | 3 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.14e-06 | 15 | 28 | 3 | MM14922 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 6.66e-06 | 19 | 28 | 3 | M27221 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 7.82e-06 | 20 | 28 | 3 | M15394 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 8.76e-06 | 67 | 28 | 4 | MM15345 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.02e-05 | 261 | 28 | 6 | MM15676 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.21e-05 | 23 | 28 | 3 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.21e-05 | 23 | 28 | 3 | MM1427 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 1.99e-05 | 27 | 28 | 3 | M27217 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 2.48e-05 | 29 | 28 | 3 | M48076 | |
| Pathway | WP_FOCAL_ADHESION | 2.99e-05 | 187 | 28 | 5 | MM15913 | |
| Pathway | KEGG_FOCAL_ADHESION | 4.02e-05 | 199 | 28 | 5 | M7253 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 4.40e-05 | 35 | 28 | 3 | M47969 | |
| Pathway | WP_PI3KAKT_SIGNALING | 4.46e-05 | 339 | 28 | 6 | M39736 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 5.21e-05 | 37 | 28 | 3 | M27797 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 7.65e-05 | 42 | 28 | 3 | M48237 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 8.21e-05 | 43 | 28 | 3 | M39565 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.01e-04 | 575 | 28 | 7 | M29853 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 1.38e-04 | 135 | 28 | 4 | MM14781 | |
| Pathway | WP_MRNA_PROCESSING | 2.15e-04 | 451 | 28 | 6 | MM15946 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL2A1 COL3A1 SMARCA2 ZNF638 SMARCA4 COL4A3 COL4A5 COL5A2 COL9A2 ARID1B | 2.67e-04 | 1432 | 28 | 10 | M509 |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 2.86e-04 | 302 | 28 | 5 | M39719 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 3.82e-04 | 502 | 28 | 6 | MM14537 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 4.07e-04 | 326 | 28 | 5 | MM15917 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 4.83e-04 | 78 | 28 | 3 | M27234 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 5.08e-04 | 190 | 28 | 4 | M8240 | |
| Pathway | WP_FOCAL_ADHESION | 6.05e-04 | 199 | 28 | 4 | M39402 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 8.60e-04 | 95 | 28 | 3 | M48268 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 8.86e-04 | 96 | 28 | 3 | M39834 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 9.13e-04 | 97 | 28 | 3 | M48262 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 9.41e-04 | 98 | 28 | 3 | M27152 | |
| Pathway | WP_THERMOGENESIS | 1.25e-03 | 108 | 28 | 3 | M39746 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 1.39e-03 | 28 | 28 | 2 | MM15957 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.60e-03 | 30 | 28 | 2 | MM15812 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.60e-03 | 30 | 28 | 2 | M39641 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 1.71e-03 | 31 | 28 | 2 | M39522 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 2.46e-03 | 137 | 28 | 3 | M48232 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 2.73e-03 | 142 | 28 | 3 | M48257 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 3.57e-03 | 45 | 28 | 2 | M39864 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 3.88e-03 | 161 | 28 | 3 | M39770 | |
| Pathway | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | 4.06e-03 | 48 | 28 | 2 | MM15410 | |
| Pathway | WP_RETT_SYNDROME | 4.06e-03 | 48 | 28 | 2 | M39759 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 4.39e-03 | 50 | 28 | 2 | M48087 | |
| Pathway | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | 4.39e-03 | 50 | 28 | 2 | M5583 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 6.89e-03 | 63 | 28 | 2 | M8 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 8.22e-03 | 69 | 28 | 2 | M48052 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 8.92e-03 | 72 | 28 | 2 | M39403 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 9.16e-03 | 73 | 28 | 2 | MM14948 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 9.16e-03 | 73 | 28 | 2 | MM15906 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.13e-02 | 237 | 28 | 3 | M27786 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.15e-02 | 82 | 28 | 2 | M27250 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 C1QC COL5A2 COL17A1 COL27A1 COL1A2 | 5.07e-20 | 62 | 37 | 10 | 28344315 |
| Pubmed | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL24A1 COL9A2 COL27A1 COL1A2 | 2.91e-17 | 175 | 37 | 11 | 28071719 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 C1QC COL5A2 COL18A1 COL24A1 COL1A2 | 1.76e-16 | 135 | 37 | 10 | 28675934 |
| Pubmed | COL3A1 COL4A3 COL4A6 C1QC COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL1A2 | 6.34e-16 | 153 | 37 | 10 | 25037231 | |
| Pubmed | COL3A1 COL4A5 COL4A6 COL5A2 COL18A1 COL24A1 COL27A1 EMID1 COL1A2 | 1.21e-13 | 167 | 37 | 9 | 22159717 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF638 SMARCA4 PPP1R10 ZNF207 EWSR1 ARID1B SF3B4 SNRPB SNAP91 PSPC1 RBM27 ZC3H4 SCAF4 | 8.89e-12 | 954 | 37 | 13 | 36373674 |
| Pubmed | 1.18e-11 | 19 | 37 | 5 | 15689378 | ||
| Pubmed | 1.45e-11 | 50 | 37 | 6 | 23658023 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ZNF638 SMARCA4 PPP1R10 ZNF207 EWSR1 SSBP2 ARID1B SF3B4 SNRPB PSPC1 RBM27 ZC3H4 SCAF4 | 4.24e-11 | 1082 | 37 | 13 | 38697112 |
| Pubmed | 5.13e-11 | 210 | 37 | 8 | 16537572 | ||
| Pubmed | 5.38e-11 | 25 | 37 | 5 | 19180518 | ||
| Pubmed | 7.56e-11 | 8 | 37 | 4 | 10382266 | ||
| Pubmed | 7.56e-11 | 8 | 37 | 4 | 3997552 | ||
| Pubmed | 7.56e-11 | 8 | 37 | 4 | 1377218 | ||
| Pubmed | 1.36e-10 | 9 | 37 | 4 | 9878537 | ||
| Pubmed | Collagen XXVII organises the pericellular matrix in the growth plate. | 1.36e-10 | 9 | 37 | 4 | 22206015 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 5.48e-10 | 283 | 37 | 8 | 30585729 | |
| Pubmed | COL4A6 is dispensable for autosomal recessive Alport syndrome. | 1.11e-09 | 3 | 37 | 3 | 27377778 | |
| Pubmed | Localization of pro-alpha 2(V) collagen transcripts in the tissues of the developing mouse embryo. | 1.11e-09 | 3 | 37 | 3 | 1297453 | |
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 1.47e-09 | 15 | 37 | 4 | 9832566 | |
| Pubmed | 4.43e-09 | 4 | 37 | 3 | 12874293 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | ZNF638 PPP1R10 ZNF207 EWSR1 SF3B4 SNRPB PSPC1 RBM27 ZC3H4 SCAF4 | 8.46e-09 | 807 | 37 | 10 | 22681889 |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 9.46e-09 | 23 | 37 | 4 | 30962207 | |
| Pubmed | COL2A1 SMARCA4 PPP1R10 COL5A2 COL18A1 ZNF207 EWSR1 SF3B4 SNRPB PSPC1 RBM27 SCAF4 | 9.96e-09 | 1371 | 37 | 12 | 36244648 | |
| Pubmed | An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. | 1.11e-08 | 5 | 37 | 3 | 9659900 | |
| Pubmed | 1.11e-08 | 5 | 37 | 3 | 15365990 | ||
| Pubmed | 1.11e-08 | 5 | 37 | 3 | 12200431 | ||
| Pubmed | 1.11e-08 | 5 | 37 | 3 | 19790048 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 2.19e-08 | 79 | 37 | 5 | 18757743 | |
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 2.21e-08 | 6 | 37 | 3 | 10534397 | |
| Pubmed | 2.21e-08 | 6 | 37 | 3 | 16230384 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 2.21e-08 | 6 | 37 | 3 | 9506531 | |
| Pubmed | Numerous BAF complex genes are mutated in Coffin-Siris syndrome. | 2.21e-08 | 6 | 37 | 3 | 25081545 | |
| Pubmed | 2.21e-08 | 6 | 37 | 3 | 8305476 | ||
| Pubmed | 2.21e-08 | 6 | 37 | 3 | 9101290 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 2.21e-08 | 6 | 37 | 3 | 9673377 | |
| Pubmed | 2.21e-08 | 6 | 37 | 3 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 2.21e-08 | 6 | 37 | 3 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 2.21e-08 | 6 | 37 | 3 | 6811420 | |
| Pubmed | 2.21e-08 | 6 | 37 | 3 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 2.21e-08 | 6 | 37 | 3 | 19275937 | |
| Pubmed | 2.21e-08 | 6 | 37 | 3 | 6988303 | ||
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 2.21e-08 | 6 | 37 | 3 | 6389236 | |
| Pubmed | 2.21e-08 | 6 | 37 | 3 | 12225806 | ||
| Pubmed | 3.87e-08 | 7 | 37 | 3 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 3.87e-08 | 7 | 37 | 3 | 8006028 | |
| Pubmed | 3.87e-08 | 7 | 37 | 3 | 17418794 | ||
| Pubmed | 3.87e-08 | 7 | 37 | 3 | 10416788 | ||
| Pubmed | 3.87e-08 | 7 | 37 | 3 | 1724753 | ||
| Pubmed | 4.37e-08 | 186 | 37 | 6 | 20452482 | ||
| Pubmed | 4.37e-08 | 186 | 37 | 6 | 20673868 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 6.18e-08 | 97 | 37 | 5 | 27559042 | |
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 9164858 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 18816857 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 29422532 | ||
| Pubmed | 6.18e-08 | 8 | 37 | 3 | 15872058 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 6.18e-08 | 8 | 37 | 3 | 10970885 | |
| Pubmed | 7.38e-08 | 347 | 37 | 7 | 16033648 | ||
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 8900172 | ||
| Pubmed | 9.27e-08 | 9 | 37 | 3 | 12101409 | ||
| Pubmed | 1.32e-07 | 10 | 37 | 3 | 2446864 | ||
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 1.32e-07 | 10 | 37 | 3 | 23129809 | |
| Pubmed | 1.32e-07 | 10 | 37 | 3 | 9136074 | ||
| Pubmed | 1.32e-07 | 10 | 37 | 3 | 14559231 | ||
| Pubmed | 1.32e-07 | 10 | 37 | 3 | 9415455 | ||
| Pubmed | The Type 3 Deiodinase Is a Critical Modulator of Thyroid Hormone Sensitivity in the Fetal Brain. | 1.56e-07 | 45 | 37 | 4 | 34248495 | |
| Pubmed | 1.82e-07 | 11 | 37 | 3 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 1.82e-07 | 11 | 37 | 3 | 7500359 | |
| Pubmed | Activation of Hypoxia Signaling in Stromal Progenitors Impairs Kidney Development. | 1.87e-07 | 47 | 37 | 4 | 28527294 | |
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 2.42e-07 | 12 | 37 | 3 | 15837576 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 2.42e-07 | 12 | 37 | 3 | 12180907 | |
| Pubmed | 2.42e-07 | 12 | 37 | 3 | 16024816 | ||
| Pubmed | 2.42e-07 | 12 | 37 | 3 | 11734557 | ||
| Pubmed | 2.57e-07 | 251 | 37 | 6 | 31076518 | ||
| Pubmed | 3.15e-07 | 13 | 37 | 3 | 17340523 | ||
| Pubmed | 3.77e-07 | 268 | 37 | 6 | 33640491 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 3.97e-07 | 922 | 37 | 9 | 27609421 | |
| Pubmed | Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome. | 4.00e-07 | 14 | 37 | 3 | 36289231 | |
| Pubmed | 4.00e-07 | 14 | 37 | 3 | 12878203 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 4.73e-07 | 457 | 37 | 7 | 32344865 | |
| Pubmed | 4.76e-07 | 146 | 37 | 5 | 27068509 | ||
| Pubmed | Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. | 5.00e-07 | 15 | 37 | 3 | 11175787 | |
| Pubmed | Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. | 5.00e-07 | 15 | 37 | 3 | 17255939 | |
| Pubmed | 5.00e-07 | 15 | 37 | 3 | 23785148 | ||
| Pubmed | Regulation of dendritic development by neuron-specific chromatin remodeling complexes. | 5.00e-07 | 15 | 37 | 3 | 17920018 | |
| Pubmed | 5.00e-07 | 15 | 37 | 3 | 11263494 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | COL3A1 ZNF638 SMARCA4 PPP1R10 EWSR1 SF3B4 COL17A1 SNRPB PSPC1 RBM27 | 5.25e-07 | 1257 | 37 | 10 | 36526897 |
| Pubmed | 6.00e-07 | 153 | 37 | 5 | 28225217 | ||
| Pubmed | 6.15e-07 | 16 | 37 | 3 | 15878328 | ||
| Pubmed | 6.15e-07 | 16 | 37 | 3 | 17881772 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 6.20e-07 | 154 | 37 | 5 | 16055720 | |
| Pubmed | 7.45e-07 | 66 | 37 | 4 | 23275444 | ||
| Pubmed | Identification of a polymorphic, neuron-specific chromatin remodeling complex. | 7.46e-07 | 17 | 37 | 3 | 12368262 | |
| Pubmed | 7.46e-07 | 17 | 37 | 3 | 11078522 | ||
| Pubmed | BAF complexes facilitate decatenation of DNA by topoisomerase IIα. | 8.94e-07 | 18 | 37 | 3 | 23698369 | |
| Pubmed | Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. | 1.06e-06 | 19 | 37 | 3 | 12110891 | |
| Pubmed | 1.06e-06 | 19 | 37 | 3 | 16932743 | ||
| Pubmed | 1.06e-06 | 19 | 37 | 3 | 31186351 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 18508913 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 8670841 | ||
| Interaction | LAIR2 interactions | 3.13e-12 | 49 | 37 | 7 | int:LAIR2 | |
| Interaction | COLGALT2 interactions | 2.30e-09 | 67 | 37 | 6 | int:COLGALT2 | |
| Interaction | MMP9 interactions | 2.30e-09 | 67 | 37 | 6 | int:MMP9 | |
| Interaction | SMC5 interactions | ZNF638 SMARCA4 PPP1R10 ZNF207 EWSR1 ARID1B SF3B4 SNRPB SNAP91 PSPC1 RBM27 ZC3H4 SCAF4 | 1.20e-08 | 1000 | 37 | 13 | int:SMC5 |
| Interaction | SS18L1 interactions | 2.33e-08 | 98 | 37 | 6 | int:SS18L1 | |
| Interaction | MECP2 interactions | SMARCA2 ZNF638 SMARCA4 PPP1R10 ZNF207 EWSR1 SSBP2 ARID1B SF3B4 SNRPB PSPC1 RBM27 ZC3H4 SCAF4 | 2.66e-08 | 1287 | 37 | 14 | int:MECP2 |
| Interaction | WBP4 interactions | 4.42e-08 | 109 | 37 | 6 | int:WBP4 | |
| Interaction | FUS interactions | ZNF638 SMARCA4 PPP1R10 COL18A1 EWSR1 SF3B4 SNRPB PSPC1 ZC3H4 ST13 SCAF4 | 6.84e-08 | 757 | 37 | 11 | int:FUS |
| Interaction | MMP2 interactions | 5.22e-07 | 87 | 37 | 5 | int:MMP2 | |
| Interaction | COL8A2 interactions | 1.02e-06 | 42 | 37 | 4 | int:COL8A2 | |
| Interaction | DCN interactions | 1.13e-06 | 43 | 37 | 4 | int:DCN | |
| Interaction | SP7 interactions | 1.16e-06 | 304 | 37 | 7 | int:SP7 | |
| Interaction | UBQLN2 interactions | C1QC EWSR1 COL9A2 C1QTNF2 SF3B4 COL17A1 EPN1 SNRPB ST13 COL1A2 | 1.17e-06 | 797 | 37 | 10 | int:UBQLN2 |
| Interaction | TRIM33 interactions | 1.33e-06 | 453 | 37 | 8 | int:TRIM33 | |
| Interaction | CD93 interactions | 1.36e-06 | 45 | 37 | 4 | int:CD93 | |
| Interaction | C1QTNF1 interactions | 1.62e-06 | 47 | 37 | 4 | int:C1QTNF1 | |
| Interaction | FN1 interactions | COL2A1 COL4A3 COL4A5 COL4A6 C1QC EWSR1 EPN1 SNRPB ST13 COL1A2 | 2.04e-06 | 848 | 37 | 10 | int:FN1 |
| Interaction | SNRPA interactions | 2.12e-06 | 482 | 37 | 8 | int:SNRPA | |
| Interaction | TBXT interactions | 2.18e-06 | 116 | 37 | 5 | int:TBXT | |
| Interaction | CIITA interactions | 3.07e-06 | 55 | 37 | 4 | int:CIITA | |
| Interaction | EWSR1 interactions | ZNF638 SMARCA4 COL5A2 ZNF207 EWSR1 SSBP2 SF3B4 SSBP3 SNRPB PSPC1 | 3.69e-06 | 906 | 37 | 10 | int:EWSR1 |
| Interaction | CPSF6 interactions | 4.05e-06 | 526 | 37 | 8 | int:CPSF6 | |
| Interaction | HABP2 interactions | 4.56e-06 | 18 | 37 | 3 | int:HABP2 | |
| Interaction | FLI1 interactions | 4.97e-06 | 62 | 37 | 4 | int:FLI1 | |
| Interaction | CAPN13 interactions | 5.41e-06 | 19 | 37 | 3 | int:CAPN13 | |
| Interaction | COL2A1 interactions | 5.65e-06 | 64 | 37 | 4 | int:COL2A1 | |
| Interaction | SPARC interactions | 6.01e-06 | 65 | 37 | 4 | int:SPARC | |
| Interaction | COL5A1 interactions | 6.01e-06 | 65 | 37 | 4 | int:COL5A1 | |
| Interaction | OSM interactions | 6.36e-06 | 20 | 37 | 3 | int:OSM | |
| Interaction | FBLN2 interactions | 6.39e-06 | 66 | 37 | 4 | int:FBLN2 | |
| Interaction | BICRA interactions | 6.78e-06 | 67 | 37 | 4 | int:BICRA | |
| Interaction | POU5F1 interactions | 8.71e-06 | 584 | 37 | 8 | int:POU5F1 | |
| Interaction | NUP35 interactions | 1.04e-05 | 424 | 37 | 7 | int:NUP35 | |
| Interaction | COL4A2 interactions | 1.06e-05 | 75 | 37 | 4 | int:COL4A2 | |
| Interaction | LHX4 interactions | 1.26e-05 | 166 | 37 | 5 | int:LHX4 | |
| Interaction | TGFBI interactions | 1.27e-05 | 25 | 37 | 3 | int:TGFBI | |
| Interaction | SNRPC interactions | 1.32e-05 | 440 | 37 | 7 | int:SNRPC | |
| Interaction | PRPF40A interactions | 1.44e-05 | 446 | 37 | 7 | int:PRPF40A | |
| Interaction | SOX7 interactions | 1.52e-05 | 82 | 37 | 4 | int:SOX7 | |
| Interaction | EPAS1 interactions | 1.54e-05 | 173 | 37 | 5 | int:EPAS1 | |
| Interaction | P4HA1 interactions | 1.57e-05 | 298 | 37 | 6 | int:P4HA1 | |
| Interaction | BRD7 interactions | 1.64e-05 | 637 | 37 | 8 | int:BRD7 | |
| Interaction | PDGFB interactions | 2.01e-05 | 88 | 37 | 4 | int:PDGFB | |
| Interaction | PLOD3 interactions | 2.01e-05 | 183 | 37 | 5 | int:PLOD3 | |
| Interaction | LHX2 interactions | 2.01e-05 | 183 | 37 | 5 | int:LHX2 | |
| Interaction | COL5A2 interactions | 2.01e-05 | 29 | 37 | 3 | int:COL5A2 | |
| Interaction | MAG interactions | 2.01e-05 | 29 | 37 | 3 | int:MAG | |
| Interaction | BGN interactions | 2.24e-05 | 30 | 37 | 3 | int:BGN | |
| Interaction | PDGFA interactions | 2.72e-05 | 32 | 37 | 3 | int:PDGFA | |
| Interaction | GATA2 interactions | 3.01e-05 | 199 | 37 | 5 | int:GATA2 | |
| Interaction | SNRPB interactions | 3.71e-05 | 517 | 37 | 7 | int:SNRPB | |
| Interaction | LHX1 interactions | 3.73e-05 | 103 | 37 | 4 | int:LHX1 | |
| Interaction | TNIP2 interactions | 4.24e-05 | 952 | 37 | 9 | int:TNIP2 | |
| Interaction | POLR2A interactions | 4.66e-05 | 536 | 37 | 7 | int:POLR2A | |
| Interaction | EFCAB13 interactions | 4.90e-05 | 6 | 37 | 2 | int:EFCAB13 | |
| Interaction | ZSWIM4 interactions | 4.90e-05 | 6 | 37 | 2 | int:ZSWIM4 | |
| Interaction | PRM2 interactions | 4.97e-05 | 39 | 37 | 3 | int:PRM2 | |
| Interaction | COL6A1 interactions | 6.15e-05 | 117 | 37 | 4 | int:COL6A1 | |
| Interaction | C1QC interactions | 6.22e-05 | 42 | 37 | 3 | int:C1QC | |
| Interaction | SFPQ interactions | 6.36e-05 | 563 | 37 | 7 | int:SFPQ | |
| Interaction | SSBP3 interactions | 6.57e-05 | 119 | 37 | 4 | int:SSBP3 | |
| Interaction | SMAD2 interactions | 6.59e-05 | 385 | 37 | 6 | int:SMAD2 | |
| Interaction | SNRPF interactions | 6.59e-05 | 385 | 37 | 6 | int:SNRPF | |
| Interaction | DDIT3 interactions | 6.78e-05 | 120 | 37 | 4 | int:DDIT3 | |
| Interaction | GMNN interactions | 7.23e-05 | 122 | 37 | 4 | int:GMNN | |
| Interaction | SUPT5H interactions | 9.07e-05 | 408 | 37 | 6 | int:SUPT5H | |
| Interaction | DBX2 interactions | 9.12e-05 | 8 | 37 | 2 | int:DBX2 | |
| Interaction | BCL9L interactions | 9.31e-05 | 48 | 37 | 3 | int:BCL9L | |
| Interaction | MDC1 interactions | 9.82e-05 | 414 | 37 | 6 | int:MDC1 | |
| Interaction | ORC6 interactions | 9.90e-05 | 49 | 37 | 3 | int:ORC6 | |
| Interaction | SNIP1 interactions | 1.02e-04 | 417 | 37 | 6 | int:SNIP1 | |
| Interaction | WWP2 interactions | 1.16e-04 | 840 | 37 | 8 | int:WWP2 | |
| Interaction | CLEC3A interactions | 1.18e-04 | 52 | 37 | 3 | int:CLEC3A | |
| Interaction | LHX8 interactions | 1.25e-04 | 53 | 37 | 3 | int:LHX8 | |
| Interaction | TOX4 interactions | 1.30e-04 | 142 | 37 | 4 | int:TOX4 | |
| Interaction | HDLBP interactions | 1.31e-04 | 855 | 37 | 8 | int:HDLBP | |
| Interaction | SNRNP40 interactions | 1.37e-04 | 637 | 37 | 7 | int:SNRNP40 | |
| Interaction | COL26A1 interactions | 1.46e-04 | 10 | 37 | 2 | int:COL26A1 | |
| Interaction | SERPINE2 interactions | 1.48e-04 | 56 | 37 | 3 | int:SERPINE2 | |
| Interaction | SMAD3 interactions | 1.49e-04 | 447 | 37 | 6 | int:SMAD3 | |
| Interaction | SREBF1 interactions | 1.61e-04 | 150 | 37 | 4 | int:SREBF1 | |
| Interaction | RAD18 interactions | 1.68e-04 | 457 | 37 | 6 | int:RAD18 | |
| Interaction | BMI1 interactions | 1.70e-04 | 659 | 37 | 7 | int:BMI1 | |
| Interaction | SMARCE1 interactions | 1.70e-04 | 287 | 37 | 5 | int:SMARCE1 | |
| Interaction | PPIA interactions | 1.70e-04 | 888 | 37 | 8 | int:PPIA | |
| Interaction | CELF1 interactions | 1.73e-04 | 288 | 37 | 5 | int:CELF1 | |
| Interaction | PCOLCE interactions | 1.79e-04 | 11 | 37 | 2 | int:PCOLCE | |
| Interaction | OBSL1 interactions | 1.89e-04 | 902 | 37 | 8 | int:OBSL1 | |
| Interaction | PRMT5 interactions | 1.98e-04 | 471 | 37 | 6 | int:PRMT5 | |
| Interaction | CEBPB interactions | SMARCA2 ZNF638 SMARCA4 ZNF207 EWSR1 SF3B4 PSPC1 ZC3H4 ST13 SCAF4 | 2.00e-04 | 1443 | 37 | 10 | int:CEBPB |
| Interaction | ST13P5 interactions | 2.14e-04 | 12 | 37 | 2 | int:ST13P5 | |
| Interaction | XRCC6 interactions | 2.30e-04 | 928 | 37 | 8 | int:XRCC6 | |
| Interaction | ACTC1 interactions | 2.33e-04 | 694 | 37 | 7 | int:ACTC1 | |
| Interaction | TOP1 interactions | 2.37e-04 | 696 | 37 | 7 | int:TOP1 | |
| Interaction | HNRNPA1 interactions | 2.60e-04 | 945 | 37 | 8 | int:HNRNPA1 | |
| Interaction | GATA1 interactions | 2.66e-04 | 171 | 37 | 4 | int:GATA1 | |
| Interaction | TLX1 interactions | 2.90e-04 | 175 | 37 | 4 | int:TLX1 | |
| Interaction | RBM25 interactions | 2.93e-04 | 323 | 37 | 5 | int:RBM25 | |
| Interaction | IDI2 interactions | 2.94e-04 | 14 | 37 | 2 | int:IDI2 | |
| Interaction | TEAD1 interactions | 2.96e-04 | 176 | 37 | 4 | int:TEAD1 | |
| Cytoband | Xq22 | 1.45e-04 | 22 | 37 | 2 | Xq22 | |
| Cytoband | 22q12.2 | 1.02e-03 | 58 | 37 | 2 | 22q12.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q32 | 3.59e-03 | 110 | 37 | 2 | chr2q32 | |
| Cytoband | 7q22.1 | 3.78e-03 | 113 | 37 | 2 | 7q22.1 | |
| GeneFamily | Collagens | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL26A1 COL27A1 COL1A2 | 1.05e-27 | 46 | 28 | 13 | 490 |
| GeneFamily | RNA binding motif containing | 7.56e-07 | 213 | 28 | 6 | 725 | |
| GeneFamily | EMI domain containing | 4.83e-05 | 7 | 28 | 2 | 540 | |
| GeneFamily | Zinc fingers CCCH-type | 1.33e-03 | 35 | 28 | 2 | 73 | |
| Coexpression | NABA_COLLAGENS | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL26A1 COL27A1 COL1A2 | 2.88e-28 | 43 | 37 | 13 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL26A1 COL27A1 COL1A2 | 4.08e-28 | 44 | 37 | 13 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL26A1 COL27A1 EMID1 COL1A2 | 5.34e-19 | 270 | 37 | 14 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL5A2 COL18A1 COL24A1 COL9A2 COL17A1 COL26A1 COL27A1 EMID1 COL1A2 | 6.92e-19 | 275 | 37 | 14 | M5884 |
| Coexpression | NABA_MATRISOME | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 C1QC COL5A2 COL18A1 COL24A1 COL9A2 C1QTNF2 COL17A1 COL26A1 CCBE1 COL27A1 EMID1 COL1A2 | 5.94e-15 | 1008 | 37 | 17 | MM17056 |
| Coexpression | NABA_MATRISOME | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 C1QC COL5A2 COL18A1 COL24A1 COL9A2 C1QTNF2 COL17A1 COL26A1 CCBE1 COL27A1 EMID1 COL1A2 | 7.94e-15 | 1026 | 37 | 17 | M5889 |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.33e-09 | 35 | 37 | 5 | MM17054 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL3A1 COL4A5 COL4A6 COL5A2 COL18A1 SNAP91 COL27A1 EMID1 COL1A2 | 2.62e-08 | 505 | 37 | 9 | M39167 |
| Coexpression | RUIZ_TNC_TARGETS_UP | 8.06e-08 | 156 | 37 | 6 | M988 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 2.96e-07 | 40 | 37 | 4 | M5887 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 1.77e-06 | 144 | 37 | 5 | M1484 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 2.02e-06 | 148 | 37 | 5 | MM1010 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 2.47e-06 | 19 | 37 | 3 | M15125 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 4.50e-06 | 23 | 37 | 3 | M48001 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 5.75e-06 | 503 | 37 | 7 | M2226 | |
| Coexpression | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN | 8.97e-06 | 93 | 37 | 4 | M4752 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 9.22e-06 | 29 | 37 | 3 | MM17055 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 9.24e-06 | 541 | 37 | 7 | MM1061 | |
| Coexpression | BENPORATH_EED_TARGETS | COL2A1 COL4A5 COL4A6 PPP1R10 COL24A1 COL9A2 SNAP91 CCBE1 COL27A1 | 1.24e-05 | 1059 | 37 | 9 | M7617 |
| Coexpression | BILANGES_SERUM_SENSITIVE_VIA_TSC2 | 1.25e-05 | 32 | 37 | 3 | MM1307 | |
| Coexpression | BILANGES_SERUM_SENSITIVE_VIA_TSC2 | 1.25e-05 | 32 | 37 | 3 | M2334 | |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | 1.42e-05 | 380 | 37 | 6 | M41703 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.53e-05 | 385 | 37 | 6 | M39264 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.64e-05 | 35 | 37 | 3 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.79e-05 | 36 | 37 | 3 | MM1212 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 1.81e-05 | 111 | 37 | 4 | M45685 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | 2.53e-05 | 421 | 37 | 6 | MM985 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 2.66e-05 | 41 | 37 | 3 | M47988 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 3.30e-05 | 44 | 37 | 3 | M18274 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 4.02e-05 | 47 | 37 | 3 | M7585 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 4.13e-05 | 137 | 37 | 4 | M40313 | |
| Coexpression | LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE | 4.56e-05 | 49 | 37 | 3 | M2899 | |
| Coexpression | HU_FETAL_RETINA_RPE | 5.31e-05 | 291 | 37 | 5 | M39271 | |
| Coexpression | FAN_OVARY_CL6_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_2 | 6.13e-05 | 300 | 37 | 5 | M41708 | |
| Coexpression | GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP | 6.84e-05 | 156 | 37 | 4 | M360 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 7.57e-05 | 58 | 37 | 3 | M178 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 8.91e-05 | 167 | 37 | 4 | M2395 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 1.02e-04 | 64 | 37 | 3 | M2572 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 1.06e-04 | 337 | 37 | 5 | MM16606 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 1.06e-04 | 65 | 37 | 3 | M39309 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING | 1.13e-04 | 1088 | 37 | 8 | MM3699 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.22e-04 | 68 | 37 | 3 | M1373 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED | 1.27e-04 | 12 | 37 | 2 | M47985 | |
| Coexpression | DESCARTES_ORGANOGENESIS_JAW_AND_TOOTH_PROGENITORS | 1.27e-04 | 12 | 37 | 2 | MM3646 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.27e-04 | 69 | 37 | 3 | M10165 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 1.32e-04 | 185 | 37 | 4 | MM1072 | |
| Coexpression | GU_PDEF_TARGETS_UP | 1.39e-04 | 71 | 37 | 3 | M3955 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.44e-04 | 72 | 37 | 3 | MM1131 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP | 1.57e-04 | 74 | 37 | 3 | M4479 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.57e-04 | 74 | 37 | 3 | M13547 | |
| Coexpression | MORI_MATURE_B_LYMPHOCYTE_DN | 1.70e-04 | 76 | 37 | 3 | M15847 | |
| Coexpression | GSE14350_TREG_VS_TEFF_UP | 1.75e-04 | 199 | 37 | 4 | M3417 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 1.90e-04 | 79 | 37 | 3 | M18400 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 1.97e-04 | 80 | 37 | 3 | MM1285 | |
| Coexpression | CHANG_POU5F1_TARGETS_UP | 2.01e-04 | 15 | 37 | 2 | M9138 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 2.05e-04 | 81 | 37 | 3 | M39253 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | 2.20e-04 | 394 | 37 | 5 | MM3724 | |
| Coexpression | MORI_MATURE_B_LYMPHOCYTE_DN | 2.20e-04 | 83 | 37 | 3 | MM596 | |
| Coexpression | ZHU_CMV_24_HR_DN | 2.28e-04 | 84 | 37 | 3 | M4065 | |
| Coexpression | DEMAGALHAES_AGING_DN | 2.30e-04 | 16 | 37 | 2 | M2145 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | 2.30e-04 | 398 | 37 | 5 | M7514 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 2.44e-04 | 86 | 37 | 3 | M2259 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP | 2.48e-04 | 218 | 37 | 4 | M1099 | |
| Coexpression | VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN | 2.60e-04 | 17 | 37 | 2 | MM1301 | |
| Coexpression | VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN | 2.60e-04 | 17 | 37 | 2 | M2302 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 2.62e-04 | 88 | 37 | 3 | M1167 | |
| Coexpression | BENPORATH_PRC2_TARGETS | 2.74e-04 | 650 | 37 | 6 | M8448 | |
| Coexpression | RODWELL_AGING_KIDNEY_NO_BLOOD_UP | 2.75e-04 | 224 | 37 | 4 | M9893 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT | 2.80e-04 | 90 | 37 | 3 | M38984 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 2.89e-04 | 91 | 37 | 3 | M40180 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 2.92e-04 | 18 | 37 | 2 | M13796 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 2.92e-04 | 18 | 37 | 2 | MM1241 | |
| Coexpression | HUMMERICH_MALIGNANT_SKIN_TUMOR_UP | 3.27e-04 | 19 | 37 | 2 | M1126 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP | 3.30e-04 | 235 | 37 | 4 | MM978 | |
| Coexpression | BAELDE_DIABETIC_NEPHROPATHY_DN | 3.54e-04 | 437 | 37 | 5 | M4665 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 3.70e-04 | 99 | 37 | 3 | M39152 | |
| Coexpression | DESCARTES_FETAL_MUSCLE_STROMAL_CELLS | 3.70e-04 | 99 | 37 | 3 | M40255 | |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | 3.80e-04 | 244 | 37 | 4 | M40312 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 3.81e-04 | 100 | 37 | 3 | MM514 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C2 | 4.00e-04 | 21 | 37 | 2 | M4767 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 4.04e-04 | 102 | 37 | 3 | MM1064 | |
| Coexpression | HUMMERICH_MALIGNANT_SKIN_TUMOR_UP | 4.81e-04 | 23 | 37 | 2 | MM492 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | 5.35e-04 | 1035 | 37 | 7 | M9898 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 5.37e-04 | 479 | 37 | 5 | M2573 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_MEG3_HIGH_FIBROBLASTS | 5.45e-04 | 113 | 37 | 3 | M43610 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 5.58e-04 | 483 | 37 | 5 | MM1082 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER | 5.70e-04 | 25 | 37 | 2 | M47986 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 6.03e-04 | 117 | 37 | 3 | M39300 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS | 6.17e-04 | 26 | 37 | 2 | M47999 | |
| Coexpression | ZHU_CMV_ALL_DN | 6.33e-04 | 119 | 37 | 3 | M14555 | |
| Coexpression | WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP | 6.65e-04 | 121 | 37 | 3 | M8475 | |
| Coexpression | NGUYEN_NOTCH1_TARGETS_UP | 6.66e-04 | 27 | 37 | 2 | M15592 | |
| Coexpression | TBK1.DF_DN | 6.90e-04 | 286 | 37 | 4 | M2864 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP | 7.27e-04 | 290 | 37 | 4 | M11616 | |
| Coexpression | GILDEA_METASTASIS | 7.69e-04 | 29 | 37 | 2 | M2386 | |
| Coexpression | NAKAMURA_CANCER_MICROENVIRONMENT_UP | 7.69e-04 | 29 | 37 | 2 | M7581 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_MACROPHAGE_AGEING | 7.83e-04 | 128 | 37 | 3 | MM3838 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 8.56e-04 | 303 | 37 | 4 | M39040 | |
| Coexpression | SENESE_HDAC2_TARGETS_DN | 8.75e-04 | 133 | 37 | 3 | M6906 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | 8.76e-04 | 534 | 37 | 5 | MM1050 | |
| CoexpressionAtlas | BM Top 100 - cervix | 5.20e-06 | 66 | 37 | 4 | BM Top 100 - cervix | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.09e-05 | 234 | 37 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 5.24e-05 | 790 | 37 | 8 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 5.58e-05 | 797 | 37 | 8 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 5.68e-05 | 799 | 37 | 8 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 5.78e-05 | 801 | 37 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | 6.09e-05 | 589 | 37 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 7.36e-05 | 607 | 37 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | 7.67e-05 | 834 | 37 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.53e-05 | 261 | 37 | 5 | gudmap_developingGonad_e12.5_epididymis_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500 | 9.02e-05 | 136 | 37 | 4 | gudmap_developingGonad_P2_epididymis_500_k2 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.21e-04 | 281 | 37 | 5 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.21e-04 | 281 | 37 | 5 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL2A1 COL4A5 COL4A6 COL5A2 COL18A1 COL9A2 SSBP3 COL27A1 EMID1 | 1.24e-04 | 1153 | 37 | 9 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_100 | 1.32e-04 | 10 | 37 | 2 | gudmap_developingGonad_e14.5_ epididymis_100_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500 | 1.39e-04 | 152 | 37 | 4 | gudmap_developingGonad_e18.5_epididymis_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.40e-04 | 290 | 37 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K2 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL2A1 COL4A5 COL4A6 COL5A2 COL9A2 SSBP2 COL26A1 CCBE1 EMID1 COL1A2 | 1.48e-04 | 1466 | 37 | 10 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.53e-04 | 156 | 37 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.80e-04 | 63 | 37 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_k1_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.80e-04 | 63 | 37 | 3 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200 | 1.95e-04 | 166 | 37 | 4 | gudmap_developingGonad_e16.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200 | 1.99e-04 | 167 | 37 | 4 | gudmap_developingGonad_e14.5_ epididymis_200 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.07e-04 | 66 | 37 | 3 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | BM Top 100 - endometrium | 2.07e-04 | 66 | 37 | 3 | BM Top 100 - endometrium | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | 2.13e-04 | 967 | 37 | 8 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | 2.13e-04 | 967 | 37 | 8 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.23e-04 | 726 | 37 | 7 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.55e-04 | 330 | 37 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.59e-04 | 744 | 37 | 7 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_100 | 3.06e-04 | 15 | 37 | 2 | gudmap_developingGonad_e12.5_epididymis_k2_100 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 3.39e-04 | 78 | 37 | 3 | PCBC_ratio_DE_from-OSKM_vs_DE_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_200 | 3.95e-04 | 17 | 37 | 2 | gudmap_developingGonad_e16.5_epididymis_200_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_100 | 4.21e-04 | 84 | 37 | 3 | gudmap_developingGonad_e14.5_ epididymis_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.36e-04 | 371 | 37 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_500 | 4.42e-04 | 206 | 37 | 4 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | 4.63e-04 | 819 | 37 | 7 | gudmap_developingGonad_e12.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.75e-04 | 210 | 37 | 4 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 5.02e-04 | 213 | 37 | 4 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | 5.02e-04 | 213 | 37 | 4 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 5.05e-04 | 591 | 37 | 6 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 5.80e-04 | 395 | 37 | 5 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | 6.04e-04 | 95 | 37 | 3 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500 | 6.41e-04 | 97 | 37 | 3 | gudmap_developingGonad_e18.5_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 6.57e-04 | 406 | 37 | 5 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.69e-04 | 230 | 37 | 4 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 6.80e-04 | 231 | 37 | 4 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | 7.01e-04 | 878 | 37 | 7 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 7.09e-04 | 413 | 37 | 5 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | 7.48e-04 | 1166 | 37 | 8 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#2 | 7.80e-04 | 642 | 37 | 6 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | 8.45e-04 | 652 | 37 | 6 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_200 | 8.64e-04 | 25 | 37 | 2 | gudmap_developingGonad_e14.5_ epididymis_200_k3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500 | 8.64e-04 | 25 | 37 | 2 | gudmap_developingGonad_e11.5_testes and mesonephros_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | 8.66e-04 | 655 | 37 | 6 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2 | 8.66e-04 | 655 | 37 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500 | 8.95e-04 | 435 | 37 | 5 | gudmap_developingGonad_e11.5_testes and mesonephros_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.99e-04 | 249 | 37 | 4 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_500 | 9.00e-04 | 109 | 37 | 3 | gudmap_developingGonad_e16.5_ovary_500_k5 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#3_top-relative-expression-ranked_200 | 9.25e-04 | 110 | 37 | 3 | gudmap_kidney_adult_RenalCapsule_k3_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_200 | 9.35e-04 | 26 | 37 | 2 | gudmap_developingGonad_e18.5_ovary_200_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#1_top-relative-expression-ranked_100 | 9.35e-04 | 26 | 37 | 2 | gudmap_developingGonad_e12.5_ovary_k1_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.32e-03 | 276 | 37 | 4 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 1.32e-03 | 978 | 37 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.33e-03 | 31 | 37 | 2 | gudmap_developingGonad_e14.5_ testes_1000_k1 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.39e-03 | 480 | 37 | 5 | ratio_MESO_vs_SC_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.52e-03 | 731 | 37 | 6 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K4 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.54e-03 | 288 | 37 | 4 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.56e-03 | 734 | 37 | 6 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.63e-03 | 498 | 37 | 5 | gudmap_developingGonad_e11.5_testes_k5_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500_K2 | 1.70e-03 | 35 | 37 | 2 | facebase_RNAseq_e9.5_MaxArch_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.04e-03 | 524 | 37 | 5 | gudmap_developingGonad_e12.5_testes_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_500 | 2.21e-03 | 40 | 37 | 2 | gudmap_developingGonad_e16.5_epididymis_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.25e-03 | 150 | 37 | 3 | gudmap_developingGonad_e12.5_ovary_k4_1000 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 2.26e-03 | 320 | 37 | 4 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 2.27e-03 | 1075 | 37 | 7 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | 2.27e-03 | 791 | 37 | 6 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 2.33e-03 | 795 | 37 | 6 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#1_top-relative-expression-ranked_500 | 2.43e-03 | 42 | 37 | 2 | gudmap_developingGonad_e11.5_testes_k1_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.44e-03 | 327 | 37 | 4 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 2.49e-03 | 806 | 37 | 6 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_200 | 2.52e-03 | 156 | 37 | 3 | gudmap_developingGonad_e12.5_ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#2_top-relative-expression-ranked_500 | 2.55e-03 | 43 | 37 | 2 | gudmap_developingGonad_e12.5_testes_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.55e-03 | 331 | 37 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_500 | 2.67e-03 | 44 | 37 | 2 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k3_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | 2.70e-03 | 819 | 37 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 2.75e-03 | 161 | 37 | 3 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_200 | 2.75e-03 | 161 | 37 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_200 | 2.79e-03 | 45 | 37 | 2 | gudmap_developingGonad_e14.5_ ovary_200_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 2.80e-03 | 162 | 37 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.87e-03 | 567 | 37 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200 | 3.00e-03 | 166 | 37 | 3 | gudmap_developingGonad_e18.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 3.12e-03 | 843 | 37 | 6 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | 3.14e-03 | 844 | 37 | 6 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.25e-03 | 354 | 37 | 4 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | 3.28e-03 | 1148 | 37 | 7 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_500 | 3.30e-03 | 49 | 37 | 2 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k3_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_200 | 3.42e-03 | 174 | 37 | 3 | gudmap_kidney_adult_RenalCapsule_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_500 | 3.43e-03 | 50 | 37 | 2 | gudmap_developingGonad_e14.5_ epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 3.48e-03 | 175 | 37 | 3 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.12e-12 | 173 | 36 | 8 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.62e-11 | 159 | 36 | 7 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-10 | 188 | 36 | 7 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-10 | 198 | 36 | 7 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.23e-10 | 199 | 36 | 7 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.31e-10 | 200 | 36 | 7 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.81e-09 | 164 | 36 | 6 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.65e-09 | 180 | 36 | 6 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.65e-09 | 180 | 36 | 6 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.83e-09 | 185 | 36 | 6 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.35e-09 | 187 | 36 | 6 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.35e-09 | 187 | 36 | 6 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.62e-09 | 188 | 36 | 6 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 8.62e-09 | 188 | 36 | 6 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | Pericytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 8.62e-09 | 188 | 36 | 6 | 14c1c88a944c66f2eaac1ce7526815dcce1f5147 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.90e-09 | 189 | 36 | 6 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 8.90e-09 | 189 | 36 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.90e-09 | 189 | 36 | 6 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.48e-09 | 191 | 36 | 6 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.78e-09 | 192 | 36 | 6 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-09 | 192 | 36 | 6 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-09 | 192 | 36 | 6 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.78e-09 | 192 | 36 | 6 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 9.78e-09 | 192 | 36 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-08 | 193 | 36 | 6 | e55f79bad6888b84b0ad5fccded498b170e3c6dc | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-08 | 194 | 36 | 6 | b294056f9bdc243263cf36dce7b62564144b9de1 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.07e-08 | 195 | 36 | 6 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-08 | 195 | 36 | 6 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.07e-08 | 195 | 36 | 6 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.07e-08 | 195 | 36 | 6 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-08 | 197 | 36 | 6 | 16758f181ef07c60aee63072e1da9572c5c85414 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.14e-08 | 197 | 36 | 6 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-08 | 197 | 36 | 6 | 69fde2d27881f8408216e231c71cfdbd96f28d45 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-08 | 198 | 36 | 6 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-08 | 198 | 36 | 6 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-08 | 198 | 36 | 6 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-08 | 198 | 36 | 6 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-08 | 198 | 36 | 6 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-08 | 198 | 36 | 6 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | 367C|World / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-08 | 198 | 36 | 6 | ab3a178f392204e2d90eb5a3b5de7849986b1eaf | |
| ToppCell | droplet-Trachea|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-08 | 199 | 36 | 6 | 1c7d30765ddb2291967da5d15664c6238c680c1d | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-08 | 199 | 36 | 6 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 1.21e-08 | 199 | 36 | 6 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | distal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.21e-08 | 199 | 36 | 6 | 1f20addc0d138fec02ed6ca4c518169c568de263 | |
| ToppCell | droplet-Trachea|droplet / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.21e-08 | 199 | 36 | 6 | b9038a1ccf3ef3123e2e39afbe6213c363437443 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-08 | 199 | 36 | 6 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-08 | 200 | 36 | 6 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | distal-mesenchymal-Myofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.25e-08 | 200 | 36 | 6 | 61854a459385cd9295be37157a8f81a2c227dff3 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.61e-08 | 134 | 36 | 5 | b959899c89d3a0363a3cd2309155280e0fe5ba88 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-07 | 142 | 36 | 5 | f4e4cde228149d5a536fbf0517ed71d81e296faf | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.52e-07 | 154 | 36 | 5 | 65dbb60f636562eeba3dafadae9c0c7db2b27476 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.68e-07 | 157 | 36 | 5 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.73e-07 | 158 | 36 | 5 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.79e-07 | 159 | 36 | 5 | cb2470b288c13e454a2a80115b0d5613b3f718e6 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.79e-07 | 159 | 36 | 5 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 2.08e-07 | 164 | 36 | 5 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-07 | 169 | 36 | 5 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.56e-07 | 171 | 36 | 5 | 2e43fb129ee9bdc3b31febc43c10f959bf0f4a7d | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.56e-07 | 171 | 36 | 5 | e219a1aa59a96e4bc3e2eacf985679174a51de41 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.79e-07 | 174 | 36 | 5 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.04e-07 | 177 | 36 | 5 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.04e-07 | 177 | 36 | 5 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.04e-07 | 177 | 36 | 5 | 7af1a19692f7fe8f691178a4e57d62bc379e3d56 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-07 | 178 | 36 | 5 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.30e-07 | 180 | 36 | 5 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.40e-07 | 181 | 36 | 5 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.40e-07 | 181 | 36 | 5 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.59e-07 | 183 | 36 | 5 | bc7dd6a40ec9c773d005c1a46f305d40cdd0a326 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 3.68e-07 | 184 | 36 | 5 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 3.68e-07 | 184 | 36 | 5 | 479e60f76c191253e23699c9dd7ef7efc08c59ad | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.79e-07 | 185 | 36 | 5 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.89e-07 | 186 | 36 | 5 | 360c3e9e5c3a943e68e6939b4a47821bfc75b553 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.99e-07 | 187 | 36 | 5 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-07 | 187 | 36 | 5 | f0c4d93f75615e570e4465fd622e3124189618a1 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-stromal_related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-07 | 187 | 36 | 5 | 3ff57da09ed8394913fb683669d7bff84a936623 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 3.99e-07 | 187 | 36 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.99e-07 | 187 | 36 | 5 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.10e-07 | 188 | 36 | 5 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.10e-07 | 188 | 36 | 5 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-07 | 189 | 36 | 5 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 4.21e-07 | 189 | 36 | 5 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-07 | 189 | 36 | 5 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.21e-07 | 189 | 36 | 5 | 4f9608b84d135268a17455661870c46ae8554a24 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-07 | 189 | 36 | 5 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | MatrixFB-Fibroblast-C|MatrixFB / shred on cell class and cell subclass (v4) | 4.32e-07 | 190 | 36 | 5 | d0106f7a21292f0b96ce4337ec3efbb1bd78dd0a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-07 | 190 | 36 | 5 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-07 | 190 | 36 | 5 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.32e-07 | 190 | 36 | 5 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.32e-07 | 190 | 36 | 5 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-07 | 191 | 36 | 5 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.43e-07 | 191 | 36 | 5 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.43e-07 | 191 | 36 | 5 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.43e-07 | 191 | 36 | 5 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-07 | 191 | 36 | 5 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-07 | 191 | 36 | 5 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.43e-07 | 191 | 36 | 5 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-07 | 191 | 36 | 5 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-07 | 191 | 36 | 5 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.55e-07 | 192 | 36 | 5 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.55e-07 | 192 | 36 | 5 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| Computational | Adhesion molecules. | 1.56e-05 | 141 | 25 | 5 | MODULE_122 | |
| Computational | Neighborhood of CDH11 | 2.47e-05 | 25 | 25 | 3 | GNF2_CDH11 | |
| Computational | Neighborhood of PTX3 | 7.54e-05 | 36 | 25 | 3 | GNF2_PTX3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.03e-04 | 50 | 25 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Drug | GK-101 | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.65e-23 | 36 | 36 | 11 | CID000161853 |
| Drug | Madecassol | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 3.63e-22 | 46 | 36 | 11 | CID000108062 |
| Drug | d-indobufen | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.01e-21 | 50 | 36 | 11 | CID000044562 |
| Drug | ridogrel | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.63e-21 | 52 | 36 | 11 | CID005362391 |
| Drug | NSC49633 | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 2.06e-21 | 53 | 36 | 11 | CID000023340 |
| Drug | AC1LAKND | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.36e-20 | 62 | 36 | 11 | CID000470146 |
| Drug | BAPN | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 6.80e-20 | 71 | 36 | 11 | CID000001647 |
| Drug | malotilate | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 6.80e-20 | 71 | 36 | 11 | CID000004006 |
| Drug | hydroxylysine | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 C1QC COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 8.83e-20 | 109 | 36 | 12 | CID000001029 |
| Drug | AC1NMZ1B | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.30e-19 | 75 | 36 | 11 | CID005034185 |
| Drug | strontium ranelate | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.76e-19 | 77 | 36 | 11 | CID006918182 |
| Drug | halofuginone lactate | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 5.59e-19 | 85 | 36 | 11 | CID000062891 |
| Drug | 4-hydroxyproline | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.23e-18 | 91 | 36 | 11 | CID000000825 |
| Drug | ticlopidine | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 5.13e-18 | 103 | 36 | 11 | CID000005472 |
| Drug | AC1L1C2F | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.09e-17 | 110 | 36 | 11 | CID000001711 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL2A1 COL3A1 SMARCA2 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.20e-17 | 162 | 36 | 12 | CID000072363 |
| Drug | PPACK | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.48e-17 | 113 | 36 | 11 | CID003036757 |
| Drug | AC1L9732 | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.64e-17 | 114 | 36 | 11 | CID000439300 |
| Drug | Tranilast sodium | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.81e-17 | 115 | 36 | 11 | CID000005527 |
| Drug | Selara | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 4.66e-17 | 125 | 36 | 11 | CID000150310 |
| Drug | DMSe | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 8.64e-17 | 132 | 36 | 11 | CID000020796 |
| Drug | pirfenidone | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.43e-16 | 138 | 36 | 11 | CID000040632 |
| Drug | DL-penicillamine | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.55e-16 | 139 | 36 | 11 | CID000004727 |
| Drug | PCR 4099 | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.55e-16 | 139 | 36 | 11 | CID000002806 |
| Drug | candesartan cilexetil | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 2.49e-16 | 145 | 36 | 11 | CID000002540 |
| Drug | khellin | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.58e-15 | 171 | 36 | 11 | CID000003828 |
| Drug | AC1L1DD6 | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 2.63e-15 | 179 | 36 | 11 | CID000002299 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 4.82e-15 | 189 | 36 | 11 | CID000001413 |
| Drug | foscarnet | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 5.11e-15 | 190 | 36 | 11 | CID000003414 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 EWSR1 COL9A2 COL17A1 COL27A1 COL1A2 | 3.57e-14 | 314 | 36 | 12 | CID000447989 |
| Drug | AC1Q6PCP | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 4.23e-14 | 230 | 36 | 11 | CID000005267 |
| Drug | prostacyclin sodium salt | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.06e-13 | 250 | 36 | 11 | CID000000159 |
| Drug | hyaluronan | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.84e-13 | 263 | 36 | 11 | CID000024759 |
| Drug | silibinin | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 4.44e-13 | 285 | 36 | 11 | CID000005213 |
| Drug | AC1L18QD | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.85e-12 | 325 | 36 | 11 | CID000000213 |
| Drug | AC1L1KMJ | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 MARCO COL27A1 COL1A2 | 4.83e-12 | 476 | 36 | 12 | CID000030956 |
| Drug | losartan | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 9.47e-12 | 378 | 36 | 11 | CID000003961 |
| Drug | colchine | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 1.09e-11 | 383 | 36 | 11 | CID000002833 |
| Drug | chondroitin sulfate | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 2.45e-11 | 413 | 36 | 11 | CID000024766 |
| Drug | Y-27632 | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 5.31e-11 | 444 | 36 | 11 | CID000005711 |
| Drug | LMWH | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 C1QTNF2 COL17A1 COL27A1 COL1A2 | 2.22e-10 | 663 | 36 | 12 | CID000000772 |
| Drug | aspirin | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 6.58e-10 | 563 | 36 | 11 | CID000002244 |
| Drug | Collagenase | 1.45e-08 | 4 | 36 | 3 | DB00048 | |
| Drug | LS-63783 | COL2A1 COL3A1 COL4A3 COL4A5 COL4A6 COL18A1 COL24A1 COL9A2 COL17A1 COL27A1 COL1A2 | 2.66e-08 | 804 | 36 | 11 | CID000000231 |
| Drug | isodesmosine | 2.08e-07 | 33 | 36 | 4 | CID000013811 | |
| Drug | pyridinoline | 4.76e-07 | 99 | 36 | 5 | CID000105068 | |
| Drug | NC-4 | 6.83e-07 | 44 | 36 | 4 | CID006420119 | |
| Drug | dermatan sulfate | 1.16e-06 | 220 | 36 | 6 | CID000032756 | |
| Drug | desmosine | 1.46e-06 | 53 | 36 | 4 | CID000025435 | |
| Drug | ascorbate-2-phosphate | 1.63e-06 | 15 | 36 | 3 | ctd:C011669 | |
| Drug | 351A | 4.06e-06 | 20 | 36 | 3 | CID000122144 | |
| Drug | L-3,4-dehydroproline | 5.30e-06 | 73 | 36 | 4 | CID000094284 | |
| Drug | YIGSR | 7.27e-06 | 79 | 36 | 4 | CID000123977 | |
| Drug | CP-331 | 7.28e-06 | 3 | 36 | 2 | CID000130967 | |
| Drug | 2d41 | 1.03e-05 | 27 | 36 | 3 | CID009543496 | |
| Drug | Trichlormethiazide [133-67-5]; Up 200; 10.6uM; HL60; HT_HG-U133A | 1.30e-05 | 194 | 36 | 5 | 2998_UP | |
| Drug | NSC-333492 | 1.46e-05 | 4 | 36 | 2 | CID000333256 | |
| Drug | Brn 2557402 | 1.46e-05 | 4 | 36 | 2 | CID000042742 | |
| Drug | Thiram | 1.72e-05 | 533 | 36 | 7 | ctd:D013893 | |
| Drug | etodolac | 1.74e-05 | 32 | 36 | 3 | CID000003308 | |
| Drug | Sirius red | 2.29e-05 | 35 | 36 | 3 | CID005486818 | |
| Drug | dimethylmalonimidate | 2.42e-05 | 5 | 36 | 2 | CID000189133 | |
| Drug | Cyclo-rgdphg | 2.42e-05 | 5 | 36 | 2 | CID006449872 | |
| Drug | AC1MRIIV | 3.19e-05 | 39 | 36 | 3 | CID003518584 | |
| Drug | Rgd Peptide | 3.53e-05 | 239 | 36 | 5 | CID000104802 | |
| Drug | BPAT-143 | 3.63e-05 | 6 | 36 | 2 | CID000146249 | |
| Drug | 4-fluoranylproline | 3.63e-05 | 6 | 36 | 2 | CID000450594 | |
| Drug | Diphosphonates | 3.63e-05 | 6 | 36 | 2 | ctd:D004164 | |
| Drug | 2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine | 3.63e-05 | 6 | 36 | 2 | ctd:C502971 | |
| Drug | PD123177 | 4.29e-05 | 43 | 36 | 3 | CID000114899 | |
| Drug | isohumulone | 5.08e-05 | 7 | 36 | 2 | CID000093090 | |
| Drug | 4-hops | 5.08e-05 | 7 | 36 | 2 | CID000135862 | |
| Drug | neo-gambogic acid | 5.08e-05 | 7 | 36 | 2 | ctd:C045863 | |
| Drug | AC1L1HWN | 5.08e-05 | 7 | 36 | 2 | CID000004323 | |
| Drug | NSC27366 | 6.77e-05 | 8 | 36 | 2 | CID000231329 | |
| Drug | Sc 40827 | 6.77e-05 | 8 | 36 | 2 | CID000127918 | |
| Drug | AC1L8RPE | 7.61e-05 | 52 | 36 | 3 | CID000407007 | |
| Drug | kalinin | 9.00e-05 | 55 | 36 | 3 | CID000032518 | |
| Drug | 1h00 | 9.50e-05 | 56 | 36 | 3 | CID000445950 | |
| Drug | trapidil | 1.00e-04 | 57 | 36 | 3 | CID000005531 | |
| Drug | AC1L9INI | 1.11e-04 | 59 | 36 | 3 | CID000445839 | |
| Drug | diphenylamine-2-carboxylate | 1.28e-04 | 164 | 36 | 4 | CID000004386 | |
| Drug | AC1Q641C | 1.29e-04 | 62 | 36 | 3 | CID000005005 | |
| Drug | MBMP | 1.32e-04 | 11 | 36 | 2 | CID000150994 | |
| Drug | meticrane | 1.32e-04 | 11 | 36 | 2 | CID000004165 | |
| Drug | 4-aminoazobenzene | 1.55e-04 | 66 | 36 | 3 | CID000006051 | |
| Drug | hematoxilina | 1.95e-04 | 183 | 36 | 4 | CID000010603 | |
| Drug | Disulfiram | 1.96e-04 | 785 | 36 | 7 | ctd:D004221 | |
| Drug | S-adenosylmethionine | 2.27e-04 | 355 | 36 | 5 | CID000001079 | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A | 2.29e-04 | 191 | 36 | 4 | 4647_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; HL60; HG-U133A | 2.43e-04 | 194 | 36 | 4 | 2009_DN | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A | 2.43e-04 | 194 | 36 | 4 | 4552_UP | |
| Drug | benzyladenine | 2.45e-04 | 77 | 36 | 3 | CID000062389 | |
| Drug | SIRIUS | 2.45e-04 | 77 | 36 | 3 | CID000091750 | |
| Drug | pyrraline | 2.52e-04 | 15 | 36 | 2 | CID000122228 | |
| Drug | dimethylnitrosamine | 2.53e-04 | 196 | 36 | 4 | CID000006124 | |
| Drug | valinomycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 5962_DN | |
| Drug | THIP Hydrochloride; Up 200; 22.6uM; PC3; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 7266_UP | |
| Drug | (R)-(+)-Atenolol [56715-13-0]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 4841_UP | |
| Drug | (1)-Nipecotic acid [498-95-3]; Down 200; 31uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 6500_DN | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 5.58e-11 | 53 | 37 | 6 | C4707243 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.81e-08 | 5 | 37 | 3 | C3281201 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 1.52e-07 | 9 | 37 | 3 | DOID:13359 (is_implicated_in) | |
| Disease | myopathy (implicated_via_orthology) | 3.91e-07 | 48 | 37 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | collagen disease (implicated_via_orthology) | 3.96e-07 | 12 | 37 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 5.15e-07 | 13 | 37 | 3 | C0265338 | |
| Disease | Leiomyomatosis, esophageal and vulval, with nephropathy | 1.53e-06 | 2 | 37 | 2 | C1839884 | |
| Disease | Leiomyoma, Epithelioid | 1.53e-06 | 2 | 37 | 2 | C0086533 | |
| Disease | Alport syndrome (is_implicated_in) | 4.59e-06 | 3 | 37 | 2 | DOID:10983 (is_implicated_in) | |
| Disease | Alport syndrome | 4.59e-06 | 3 | 37 | 2 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 4.59e-06 | 3 | 37 | 2 | cv:CN076135 | |
| Disease | Hematuria, Benign Familial | 9.17e-06 | 4 | 37 | 2 | C0241908 | |
| Disease | Stickler syndrome (is_implicated_in) | 9.17e-06 | 4 | 37 | 2 | DOID:0080046 (is_implicated_in) | |
| Disease | Alport Syndrome | 9.17e-06 | 4 | 37 | 2 | C1567741 | |
| Disease | Early Pregnancy Loss | 1.06e-05 | 109 | 37 | 4 | C3830362 | |
| Disease | Miscarriage | 1.06e-05 | 109 | 37 | 4 | C4552766 | |
| Disease | Spontaneous abortion | 1.06e-05 | 109 | 37 | 4 | C0000786 | |
| Disease | Abortion, Tubal | 1.06e-05 | 109 | 37 | 4 | C0000822 | |
| Disease | Stickler syndrome, type 1 | 1.53e-05 | 5 | 37 | 2 | C2020284 | |
| Disease | Stickler syndrome | 1.53e-05 | 5 | 37 | 2 | cv:C0265253 | |
| Disease | Ehlers-Danlos Syndrome | 1.53e-05 | 5 | 37 | 2 | C0013720 | |
| Disease | Alport Syndrome, X-Linked | 1.53e-05 | 5 | 37 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 1.53e-05 | 5 | 37 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 1.53e-05 | 5 | 37 | 2 | C1567744 | |
| Disease | Hereditary hearing loss and deafness | 3.35e-05 | 146 | 37 | 4 | cv:C0236038 | |
| Disease | Ehlers-Danlos syndrome | 4.26e-05 | 8 | 37 | 2 | cv:C0013720 | |
| Disease | neuroimaging measurement | 4.38e-05 | 1069 | 37 | 8 | EFO_0004346 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 5.48e-05 | 9 | 37 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | brain measurement, neuroimaging measurement | 5.81e-05 | 550 | 37 | 6 | EFO_0004346, EFO_0004464 | |
| Disease | Retinal Detachment | 8.35e-05 | 11 | 37 | 2 | C0035305 | |
| Disease | Cleft Palate | 1.45e-04 | 81 | 37 | 3 | C0008925 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 2.58e-04 | 19 | 37 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Multiple Epiphyseal Dysplasia | 2.87e-04 | 20 | 37 | 2 | C0026760 | |
| Disease | Liver Cirrhosis | 2.94e-04 | 103 | 37 | 3 | C0023890 | |
| Disease | Fibrosis, Liver | 3.12e-04 | 105 | 37 | 3 | C0239946 | |
| Disease | Renal glomerular disease | 3.81e-04 | 23 | 37 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 3.81e-04 | 23 | 37 | 2 | C4521256 | |
| Disease | Heart valve disease | 4.88e-04 | 26 | 37 | 2 | C0018824 | |
| Disease | age at menarche | 8.32e-04 | 594 | 37 | 5 | EFO_0004703 | |
| Disease | Cataract | 9.91e-04 | 37 | 37 | 2 | C0086543 | |
| Disease | end stage renal disease (is_implicated_in) | 1.22e-03 | 41 | 37 | 2 | DOID:783 (is_implicated_in) | |
| Disease | cortical surface area measurement | 1.25e-03 | 1345 | 37 | 7 | EFO_0010736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MLTVPGPPGPPGAMG | 816 | Q9UMD9 | |
| GGPGGPPGPLMEQMG | 616 | Q01844 | |
| GAPGQQGPFGMPGMP | 1446 | Q14031 | |
| IGMMGFPGAIGPPGP | 891 | Q01955 | |
| PGMSQQGGPGMGPPM | 991 | Q8NFD5 | |
| PGAGFGMPPAGTGMP | 836 | O60641 | |
| GPMGPMGPRGPPGPA | 201 | P02458 | |
| PGGMPGNFPGGMPGM | 286 | Q8NFI4 | |
| PGGMPGNFPGGMPGM | 286 | P50502 | |
| MLMPPMPGPGPGPGP | 331 | Q9P2N5 | |
| GPPGAPGPSGMMGRM | 46 | Q9BXJ5 | |
| LGFGMRGMPGPPGPP | 1246 | P39060 | |
| KNGPMGPPGMPGVPG | 86 | P02747 | |
| GPPGMPGVPGPMGIP | 91 | P02747 | |
| GPMGLMGPRGPPGAA | 91 | P08123 | |
| GMPGPPGQPGPRGSM | 271 | Q6UXH8 | |
| PGQPGPRGSMGPMGP | 276 | Q6UXH8 | |
| GEMGMMGPPGPPGPL | 896 | P29400 | |
| AVGMMGPPGPPGPPG | 551 | Q14055 | |
| RGAHGMPGKPGPMGP | 356 | P05997 | |
| MPGKPGPMGPLGIPG | 361 | P05997 | |
| KGDRGMMGPPGVPGP | 1011 | Q8IZC6 | |
| MMGPPGVPGPKGSMG | 1016 | Q8IZC6 | |
| AMGMPGAPGPPGPPA | 161 | Q9UEW3 | |
| PLGGGPGLPPMMPPG | 551 | Q9Y6I3 | |
| GGPGMRGMPGSPGGP | 531 | P02461 | |
| AGSRGPMGMRGPPGP | 211 | Q96A84 | |
| PMGMRGPPGPQGPPG | 216 | Q96A84 | |
| MHRGPPPGPGGFAMP | 886 | O95104 | |
| PPGPGGFAMPPPHGM | 891 | O95104 | |
| GPRGLPGEMGRPGPP | 241 | Q96A83 | |
| PGMPGMNMGPGGGRP | 206 | P81877 | |
| QRMNPPRGMGPMGPG | 201 | Q9BWW4 | |
| GTGMRPPHPGMGPPQ | 96 | P51531 | |
| RPHGMGGPNMPPPGP | 251 | P51532 | |
| PPPMGRGAPPPGMMG | 176 | P14678 | |
| RGAPPPGMMGPPPGM | 181 | P14678 | |
| PGMMGPPPGMRPPMG | 186 | P14678 | |
| RPPMGPPMGIPPGRG | 196 | P14678 | |
| PPMGIPPGRGTPMGM | 201 | P14678 | |
| PPGRGTPMGMPPPGM | 206 | P14678 | |
| VGPPGEMGMEGPPGT | 1001 | Q17RW2 | |
| TIPGPPMGPGPAMGP | 431 | Q8WXF1 | |
| GGPPGPMGPGPNMGP | 606 | Q9UPT8 | |
| PMGPGPNMGPPGPMG | 611 | Q9UPT8 | |
| PNMGPPGPMGGPMHP | 616 | Q9UPT8 | |
| DMPMGPGMNPGPPMG | 651 | Q9UPT8 | |
| PGMNPGPPMGPGGPP | 656 | Q9UPT8 | |
| GPPMGPGGPPMMPYG | 661 | Q9UPT8 | |
| MPMGGMMPPGPGIPP | 186 | O43670 | |
| PMRGGPMRGGPGPGP | 686 | Q96QC0 | |
| PMGHPGPMPPHGMRG | 361 | Q15427 | |
| NPSGMRPPGPFMRPG | 21 | Q14966 | |
| RPPGPFMRPGSMGLP | 26 | Q14966 |